AB 2789: Health care practitioners: prescriptions: electronic data transmission.
- Session Year: 2017-2018
- House: Assembly
- Latest Version Date: 2018-09-17
Existing law provides for the regulation of health care practitioners and requires prescription drugs to be ordered and dispensed in accordance with the Pharmacy Law. The Pharmacy Law provides that a prescription is an oral, written, or electronic data transmission order and requires electronic data transmission prescriptions to be transmitted and processed in accordance with specified requirements.
This bill, on and after January 1, 2022, would require health care practitioners authorized to issue prescriptions to have the capability to transmit electronic data transmission prescriptions, and would require pharmacies to have the capability to receive those transmissions. The bill would require those health care practitioners to issue prescriptions as an electronic data transmission prescription, unless specified exceptions are met. The bill would not require the pharmacy to verify that a written, oral, or faxed prescription satisfies the specified exemptions. The bill would require the pharmacy receiving the electronic data transmission prescription to immediately notify the prescriber if the electronic data transmission prescription fails, is incomplete, or is otherwise not appropriately received. The bill would require the pharmacy to transfer or forward the prescription to another pharmacy at the request of the patient, as specified. The bill would exempt from these provisions a health care practitioner, pharmacist, or pharmacy when providing health care services to specified individuals under the jurisdiction of the Department of Corrections and Rehabilitation. The bill would require that a health care practitioner, pharmacist, or pharmacy who fails to meet the applicable requirements imposed by this bill be referred to the appropriate state professional licensing board solely for administrative sanctions, as provided.
Existing law provides for the regulation of health care practitioners and requires prescription drugs to be ordered and dispensed in accordance with the Pharmacy Law. The Pharmacy Law provides that a prescription is an oral, written, or electronic data transmission order and requires electronic data transmission prescriptions to be transmitted and processed in accordance with specified requirements.
This bill, on and after January 1, 2022, would require health care practitioners authorized to issue prescriptions to have the capability to transmit electronic data transmission prescriptions, and would require pharmacies to have the capability to receive those transmissions. The bill would require those health care practitioners to issue prescriptions as an electronic data transmission prescription, unless specified exceptions are met. The bill would not require the pharmacy to verify that a written, oral, or faxed prescription satisfies the specified exemptions. The bill would require the pharmacy receiving the electronic data transmission prescription to immediately notify the prescriber if the electronic data transmission prescription fails, is incomplete, or is otherwise not appropriately received. The bill would require the pharmacy to transfer or forward the prescription to another pharmacy at the request of the patient, as specified. The bill would exempt from these provisions a health care practitioner, pharmacist, or pharmacy when providing health care services to specified individuals under the jurisdiction of the Department of Corrections and Rehabilitation. The bill would require that a health care practitioner, pharmacist, or pharmacy who fails to meet the applicable requirements imposed by this bill be referred to the appropriate state professional licensing board solely for administrative sanctions, as provided.
Existing law provides for the regulation of health care practitioners and requires prescription drugs to be ordered and dispensed in accordance with the Pharmacy Law. The Pharmacy Law provides that a prescription is an oral, written, or electronic data transmission order and requires electronic data transmission prescriptions to be transmitted and processed in accordance with specified requirements.
This bill, on and after January 1, 2022, would require health care practitioners authorized to issue prescriptions to have the capability to transmit electronic data transmission prescriptions, and would require pharmacies to have the capability to receive those transmissions. The bill would require those health care practitioners to issue prescriptions as an electronic data transmission prescription, unless specified exceptions are met. The bill would not require the pharmacy to verify that a written, oral, or faxed prescription satisfies the specified exemptions. The bill would require the pharmacy receiving the electronic data transmission prescription to immediately notify the prescriber if the electronic data transmission prescription fails, is incomplete, or is otherwise not appropriately received. The bill would require the pharmacy to transfer or forward the prescription to another pharmacy at the request of the patient, as specified. The bill would exempt from these provisions a health care practitioner, pharmacist, or pharmacy when providing health care services to specified individuals under the jurisdiction of the Department of Corrections and Rehabilitation. The bill would require that a health care practitioner, pharmacist, or pharmacy who fails to meet the applicable requirements imposed by this bill be referred to the appropriate state professional licensing board solely for administrative sanctions, as provided.
Existing law provides for the regulation of health care practitioners and requires prescription drugs to be ordered and dispensed in accordance with the Pharmacy Law. The Pharmacy Law provides that a prescription is an oral, written, or electronic data transmission order and requires electronic data transmission prescriptions to be transmitted and processed in accordance with specified requirements.
This bill, on and after January 1, 2022, would require health care practitioners authorized to issue prescriptions to have the capability to transmit electronic data transmission prescriptions, and would require pharmacies to have the capability to receive those transmissions. The bill would require those health care practitioners to issue prescriptions as an electronic data transmission prescription, unless specified exceptions are met. The bill would not require the pharmacy to verify that a written, oral, or faxed prescription satisfies the specified exemptions. The bill would require the pharmacy receiving the electronic data transmission prescription to immediately notify the prescriber if the electronic data transmission prescription fails, is incomplete, or is otherwise not appropriately received. The bill would authorize require the pharmacy to transmit transfer or forward the prescription to another pharmacy at the request of the patient, as specified. The bill would require that a health care professional who violates specified provisions to practitioner, pharmacist, or pharmacy who fails to meet the applicable requirements imposed by this bill be referred to the appropriate state professional licensing board solely for administrative sanctions, as provided.
Existing law provides for the regulation of health care practitioners and requires prescription drugs to be ordered and dispensed in accordance with the Pharmacy Law. The Pharmacy Law provides that a prescription is an oral, written, or electronic data transmission order and requires electronic data transmission prescriptions to be transmitted and processed in accordance with specified requirements.
This bill, on and after January 1, 2020, 2022, would require health care practitioners authorized to issue prescriptions to have the capability to transmit electronic data transmission prescriptions, and would require pharmacies to have the capability to receive those transmissions. The bill, on and after January 1, 2021, bill would require those health care practitioners to issue prescriptions as an electronic data transmission prescription, unless specified exceptions are met. The bill would not require the pharmacy to verify that a written, oral, or faxed prescription satisfies the specified exemptions. The bill would require the pharmacy receiving the electronic data transmission prescription to immediately notify the prescriber if the electronic data transmission prescription fails, is incomplete, or is otherwise not appropriately received. The bill would authorize the pharmacy to transmit the prescription to another pharmacy at the request of the patient, as specified. The bill would make a violation of these provisions unprofessional conduct and would subject the health care practitioner to discipline by the board charged with regulating his or her license. require a health care professional who violates specified provisions to be referred to the appropriate state professional licensing board solely for administrative sanctions, as provided.
Existing law provides for the regulation of health care practitioners and requires prescription drugs to be ordered and dispensed in accordance with the Pharmacy Law. Existing law, the The Pharmacy Law, Law provides that a prescription is an oral, written, or electronic data transmission order and requires electronic data transmission prescriptions to be transmitted and processed in accordance with specified requirements.
This bill, on and after January 1, 2020, would require health care practitioners authorized to issue prescriptions to have the capability to transmit electronic data transmission prescriptions, and would require pharmacies to have the capability to receive those transmissions. The bill, on and after January 1, 2021, would require those health care practitioners to issue prescriptions as an electronic data transmission prescription, unless specified exceptions are met. The bill would not require the pharmacy to verify that a written, oral, or faxed prescription satisfies the specified exemptions. The bill would require the pharmacy receiving the electronic data transmission prescription to immediately notify the prescriber if the electronic data transmission prescription fails, is incomplete, or is otherwise not appropriately received. The bill would authorize the pharmacy to transmit the prescription to another pharmacy at the request of the patient, as specified. The bill would make a violation of these provisions unprofessional conduct and would subject the health care practitioner to discipline by the board charged with regulating his or her license.
Existing law provides for the regulation of health care practitioners and requires prescription drugs to be ordered and dispensed in accordance with the Pharmacy Law. Existing law, the Pharmacy Law, provides that a prescription is an oral, written, or electronic transmission order and requires electronic transmission prescriptions to be transmitted and processed in accordance with specified requirements.
This bill, on and after January 1, 2020, would require health care practitioners authorized to issue prescriptions to have the capability to transmit electronic transmission prescriptions, and would require pharmacies to have the capability to receive those transmissions. The bill, on and after January 1, 2021, would require those health care practitioners to issue prescriptions as an electronic transmission prescription, unless specified exceptions are met. The bill would not require the pharmacy to verify that a written, oral, or faxed prescription satisfies the specified exemptions. The bill would require the pharmacy receiving the electronic transmission prescription to immediately notify the prescriber if the electronic transmission prescription fails, is incomplete, or is otherwise not appropriately received. The bill would authorize the pharmacy to transmit the prescription to another pharmacy at the request of the patient, as specified. The bill would make a violation of these provisions unprofessional conduct and would subject the health care practitioner to discipline by the board charged with regulating his or her license.
(a)On and after January 1, 2022, a health care practitioner authorized to issue a prescription pursuant to Section 4040 shall have the capability to issue an electronic data transmission prescription, as defined under Section 4040, on behalf of a patient and to transmit that electronic data transmission prescription to a pharmacy selected by the patient.
(b)On and after January 1, 2022, a pharmacy, pharmacist, or other practitioner authorized under California law to dispense or furnish a prescription pursuant to Section 4040 shall have the capability to receive an electronic data transmission prescription on behalf of a patient.
(c)For a prescription for a controlled substance, as defined by Section 4021, generation and transmission of the electronic data transmission prescription shall comply with Parts 1300, 1304, 1306, and 1311 of Title 21 of the Code of Federal Regulations, as amended from time to time.
(d)On and after January 1, 2022, a prescription prescribed by a health care practitioner shall be issued as an electronic data transmission prescription. This subdivision shall not apply to prescriptions issued pursuant to subdivision (e).
(e)Subdivision (d) shall not apply to any of the following:
(1)The prescription is issued pursuant to Section 11159.2 of the Health and Safety Code.
(2)An electronic data transmission prescription is not available due to a temporary technological or electrical failure. For purposes of this paragraph, temporary technological or electrical failure means failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified electronic data transmission prescription application used to transmit the prescription.
(3)The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
(4)(A)The prescription is issued in a hospital emergency department or urgent care clinic and one or more of the following conditions are present:
(i)The patient resides outside California.
(ii)The patient resides outside the geographic area of the hospital.
(iii)The patient is homeless or indigent and does not have a preferred pharmacy.
(iv)The prescription is issued at a time when a patients regular or preferred pharmacy is likely to be closed.
(B)Under any of the conditions described in subparagraph (A), a prescription shall be electronically issued but does not require electronic transmission and may be provided directly to the patient.
(5)The prescription is issued by a veterinarian.
(6)The prescription is for eyeglasses or contact lenses.
(7)The prescribing health care practitioner and the dispenser are the same entity.
(8)The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain substances prescribed by an electronic data transmission prescription in a timely manner, and the delay would adversely impact the patients medical condition.
(9)The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs SCRIPT standard, as amended from time to time.
(f)A health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an electronic data transmission prescription shall document the reason in the patients medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented the electronic data transmission of the prescription.
(g)A pharmacy that receives an electronic data transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient shall, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic data transmission prescription to an alternative pharmacy designated by the requester.
(h)If a pharmacy, or its staff, is aware than an attempted transmission of an electronic data transmission prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner.
(i)A pharmacist who receives a written, oral, or faxed prescription shall not be required to verify that the prescription properly falls under one of the exceptions in subdivision (e). Pharmacists may continue to dispense medications from legally valid written, oral, or fax prescriptions pursuant to this division.
(j)A health care practitioner, pharmacist, or pharmacy who fails to meet the applicable requirements of this section shall be referred to the appropriate state professional licensing board solely for administrative sanctions, as deemed appropriate by that board. This section does not create a private right of action against a health care practitioner. This section does not limit a health care practitioners liability for the negligent failure to diagnose or treat a patient.
(k)This section shall not apply to a health care practitioner, pharmacist, or pharmacy when providing health care services to an inmate, individual on parole, or youth under the jurisdiction of the Department of Corrections and Rehabilitation.
(a)On and after January 1, 2022, a health care practitioner authorized to issue a prescription pursuant to Section 4040 shall have the capability to issue an electronic data transmission prescription, as defined under Section 4040, on behalf of a patient and to transmit that electronic data transmission prescription to a pharmacy selected by the patient.
(b)On and after January 1, 2022, a pharmacy, pharmacist, or other practitioner authorized under California law to dispense or furnish a prescription pursuant to Section 4040 shall have the capability to receive an electronic data transmission prescription on behalf of a patient.
(c)For a prescription for a controlled substance, as defined by Section 4021, generation and transmission of the electronic data transmission prescription shall comply with Parts 1300, 1304, 1306, and 1311 of Title 21 of the Code of Federal Regulations, as amended from time to time.
(d)On and after January 1, 2022, a prescription prescribed by a health care practitioner shall be issued as an electronic data transmission prescription. This subdivision shall not apply to prescriptions issued pursuant to subdivision (e).
(e)Subdivision (d) shall not apply to any of the following:
(1)The prescription is issued pursuant to Section 11159.2 of the Health and Safety Code.
(2)An electronic data transmission prescription is not available due to a temporary technological or electrical failure. For purposes of this paragraph, temporary technological or electrical failure means failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified electronic data transmission prescription application used to transmit the prescription.
(3)The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
(4)(A)The prescription is issued in a hospital emergency department or urgent care clinic and one or more of the following conditions are present:
(i)The patient resides outside California.
(ii)The patient resides outside the geographic area of the hospital.
(iii)The patient is homeless or indigent and does not have a preferred pharmacy.
(iv)The prescription is issued at a time when a patients regular or preferred pharmacy is likely to be closed.
(B)Under any of the conditions described in subparagraph (A), a prescription shall be electronically issued but does not require electronic transmission and may be provided directly to the patient.
(5)The prescription is issued by a veterinarian.
(6)The prescription is for eyeglasses or contact lenses.
(7)The prescribing health care practitioner and the dispenser are the same entity.
(8)The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain substances prescribed by an electronic data transmission prescription in a timely manner, and the delay would adversely impact the patients medical condition.
(9)The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs SCRIPT standard, as amended from time to time.
(f)A health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an electronic data transmission prescription shall document the reason in the patients medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented the electronic data transmission of the prescription.
(g)A pharmacy that receives an electronic data transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient shall, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic data transmission prescription to an alternative pharmacy designated by the requester.
(h)If a pharmacy, or its staff, is aware than an attempted transmission of an electronic data transmission prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner.
(i)A pharmacist who receives a written, oral, or faxed prescription shall not be required to verify that the prescription properly falls under one of the exceptions in subdivision (e). Pharmacists may continue to dispense medications from legally valid written, oral, or fax prescriptions pursuant to this division.
(j)A health care practitioner, pharmacist, or pharmacy who fails to meet the applicable requirements of this section shall be referred to the appropriate state professional licensing board solely for administrative sanctions, as deemed appropriate by that board. This section does not create a private right of action against a health care practitioner. This section does not limit a health care practitioners liability for the negligent failure to diagnose or treat a patient.
(k)This section shall not apply to a health care practitioner, pharmacist, or pharmacy when providing health care services to an inmate, individual on parole, or youth under the jurisdiction of the Department of Corrections and Rehabilitation.
(a)On and after January 1, 2022, a health care practitioner authorized to issue a prescription pursuant to Section 4040 shall have the capability to issue an electronic data transmission prescription, as defined under Section 4040, on behalf of a patient and to transmit that electronic data transmission prescription to a pharmacy selected by the patient.
(b)On and after January 1, 2022, a pharmacy, pharmacist, or other practitioner authorized under California law to dispense or furnish a prescription pursuant to Section 4040 shall have the capability to receive an electronic data transmission prescription on behalf of a patient.
(c)For a prescription for a controlled substance, as defined by Section 4021, generation and transmission of the electronic data transmission prescription shall comply with Parts 1300, 1304, 1306, and 1311 of Title 21 of the Code of Federal Regulations, as amended from time to time.
(d)On and after January 1, 2022, a prescription prescribed by a health care practitioner shall be issued as an electronic data transmission prescription. This subdivision shall not apply to prescriptions issued pursuant to subdivision (e).
(e)Subdivision (d) shall not apply to any of the following:
(1)The prescription is issued pursuant to Section 11159.2 of the Health and Safety Code.
(2)An electronic data transmission prescription is not available due to a temporary technological or electrical failure. For purposes of this paragraph, temporary technological or electrical failure means failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified electronic data transmission prescription application used to transmit the prescription.
(3)The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
(4)(A)The prescription is issued in a hospital emergency department or urgent care clinic and one or more of the following conditions are present:
(i)The patient resides outside California.
(ii)The patient resides outside the geographic area of the hospital.
(iii)The patient is homeless or indigent and does not have a preferred pharmacy.
(iv)The prescription is issued at a time when a patients regular or preferred pharmacy is likely to be closed.
(B)Under any of the conditions described in subparagraph (A), a prescription shall be electronically issued but does not require electronic transmission and may be provided directly to the patient.
(5)The prescription is issued by a veterinarian.
(6)The prescription is for eyeglasses or contact lenses.
(7)The prescribing health care practitioner and the dispenser are the same entity.
(8)The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain substances prescribed by an electronic data transmission prescription in a timely manner, and the delay would adversely impact the patients medical condition.
(9)The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs SCRIPT standard, as amended from time to time.
(f)A health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an electronic data transmission prescription shall document the reason in the patients medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented the electronic data transmission of the prescription.
(g)A pharmacy that receives an electronic data transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient shall, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic data transmission prescription to an alternative pharmacy designated by the requester.
(h)If a pharmacy, or its staff, is aware than an attempted transmission of an electronic data transmission prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner.
(i)A pharmacist who receives a written, oral, or faxed prescription shall not be required to verify that the prescription properly falls under one of the exceptions in subdivision (e). Pharmacists may continue to dispense medications from legally valid written, oral, or fax prescriptions pursuant to this division.
(j)A health care practitioner, pharmacist, or pharmacy who fails to meet the applicable requirements of this section shall be referred to the appropriate state professional licensing board solely for administrative sanctions, as deemed appropriate by that board. This section does not create a private right of action against a health care practitioner. This section does not limit a health care practitioners liability for the negligent failure to diagnose or treat a patient.
(k)This section shall not apply to a health care practitioner, pharmacist, or pharmacy when providing health care services to an inmate, individual on parole, or youth under the jurisdiction of the Department of Corrections and Rehabilitation.
(a)On and after January 1, 2022, a health care practitioner authorized to issue a prescription pursuant to Section 4040 shall have the capability to issue an electronic data transmission prescription, as defined under Section 4040, on behalf of a patient and to transmit that electronic data transmission prescription to a pharmacy selected by the patient.
(b)On and after January 1, 2022, a pharmacy, pharmacist, or other practitioner authorized under California law to dispense or furnish a prescription pursuant to Section 4040 shall have the capability to receive an electronic data transmission prescription on behalf of a patient.
(c)For a prescription for a controlled substance, as defined by Section 4021, generation and transmission of the electronic data transmission prescription shall comply with Parts 1300, 1304, 1306, and 1311 of Title 21 of the Code of Federal Regulations, as amended from time to time.
(d)On and after January 1, 2022, a prescription prescribed by a health care practitioner shall be issued as an electronic data transmission prescription. This subdivision shall not apply to prescriptions issued pursuant to subdivisions (e) and (f). subdivision (e).
(e)Subdivision (d) shall not apply to any of the following:
(1)The prescription is issued pursuant to Section 11159.2 of the Health and Safety Code.
(2)An electronic data transmission prescription is not available due to a temporary technological or electrical failure. For purposes of this paragraph, temporary technological or electrical failure means failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified electronic data transmission prescription application used to transmit the prescription.
(3)The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
(4)(A)The prescription is issued in a hospital emergency department or urgent care clinic and one or more of the following conditions are present:
(i)The patient resides outside California.
(ii)The patient resides outside the geographic area of the hospital.
(iii)The patient is homeless or indigent and does not have a preferred pharmacy.
(iv)The prescription is issued at a time when a patients regular or preferred pharmacy is likely to be closed.
(B)Under any of the conditions described in subparagraph (A), a prescription shall be electronically issued but does not require electronic transmission and may be provided directly to the patient.
(4)(5)The prescription is issued by a veterinarian.
(5)(6)The prescription is for eyeglasses or contact lenses.
(6)(7)The prescribing health care practitioner and the dispenser are the same entity.
(7)(8)The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances prescribed by an electronic data transmission prescription in a timely manner, and the delay would adversely impact the patients medical condition.
(8)(9)The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs SCRIPT standard, as amended from time to time.
(f)(1)Subdivision (d) shall not apply when the prescription is issued in a hospital emergency department or urgent care clinic and one or more of the following conditions are present:(A)The patient resides outside California.(B)The patient resides outside the geographic service area of the hospital.(C)The patient is homeless or indigent and does not have a regular or preferred pharmacy.(D)The prescription is issued at a time when a patients regular or preferred pharmacy is likely to be closed.(2)A prescription issued pursuant to paragraph (1) does not require electronic transmission and may be provided directly to the patient. (g)(f)A health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an electronic data transmission prescription shall document the reason in the patients medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented the electronic data transmission of the prescription.
(h)(g)A pharmacy that receives an electronic data transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient may, shall, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic data transmission prescription to an alternative pharmacy designated by the requester.
(i)(h)If a pharmacy, or its staff, is aware than an attempted transmission of an electronic data transmission prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner.
(j)(i)A pharmacist who receives a written, oral, or faxed prescription shall not be required to verify that the prescription properly falls under one of the exceptions in subdivision (e) or (f). (e). Pharmacists may continue to dispense medications from legally valid written, oral, or fax prescriptions pursuant to this division.
(k)(j)A health care practitioner practitioner, pharmacist, or pharmacy who fails to meet the electronic capability standards of subdivisions (a) and (b) and who fails to electronically transmit prescriptions as required by subdivision (d) applicable requirements of this section shall be referred to the appropriate state professional licensing board solely for administrative sanctions, as deemed appropriate by that board. This section does not create a private right of action against a health care practitioner. This section does not limit a health care practitioners liability for the negligent failure to diagnose or treat a patient.
(a)On and after January 1, 2020, 2022, a health care practitioner authorized to issue a prescription pursuant to Section 4040 shall have the capability to issue an electronic data transmission prescription, as defined under Section 4040, on behalf of a patient and to transmit that electronic data transmission prescription to a pharmacy selected by the patient.
(b)On and after January 1, 2020, 2022, a pharmacy, pharmacist, or other practitioner authorized under California law to dispense or furnish a prescription pursuant to Section 4040 shall have the capability to receive an electronic data transmission prescription on behalf of a patient.
(c)For a prescription for a controlled substance, as defined by Section 4021, generation and transmission of the electronic data transmission prescription shall comply with Parts 1300, 1304, 1306, and 1311 of Title 21 of the Code of Federal Regulations, as amended from time to time.
(d)On and after January 1, 2021, 2022, a prescription prescribed by a health care practitioner shall be issued as an electronic data transmission prescription. This subdivision shall not apply to prescriptions issued pursuant to subdivision (e). subdivisions (e) and (f).
(e)Subdivision (d) shall not apply to any of the following:
(1)The prescription is issued pursuant to Section 11159.2 of the Health and Safety Code.
(2)An electronic data transmission prescription is not available due to a temporary technological or electrical failure. For purposes of this paragraph, temporary technological or electrical failure means failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified electronic data transmission prescription application used to transmit the prescription.
(3)The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
(4)The prescription is issued by a veterinarian.
(5)The prescription is for eyeglasses or contact lenses.
(6)The prescribing health care practitioner and the dispenser are the same entity.
(7)The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances prescribed by an electronic data transmission prescription in a timely manner, and the delay would adversely impact the patients medical condition.
(8)The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs SCRIPT standard, as amended from time to time.
(f)(1)Subdivision (d) shall not apply when the prescription is issued in a hospital emergency department or urgent care clinic and one or more of the following conditions are present:
(A)The patient resides outside California.
(B)The patient resides outside the geographic service area of the hospital.
(C)The patient is homeless or indigent and does not have a regular or preferred pharmacy.
(D)The prescription is issued at a time when a patients regular or preferred pharmacy is likely to be closed.
(2)A prescription issued pursuant to paragraph (1) does not require electronic transmission and may be provided directly to the patient.
(f)(g)A health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an electronic data transmission prescription shall document the reason in the patients medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented the electronic data transmission of the prescription.
(g)(h)A pharmacy that receives an electronic data transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient may, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic data transmission prescription to an alternative pharmacy designated by the requester.
(h)(i)If a pharmacy, or its staff, is aware than an attempted transmission of an electronic data transmission prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner.
(i)(j)A pharmacist who receives a written, oral, or faxed prescription shall not be required to verify that the prescription properly falls under one of the exceptions in subdivision (e). (e) or (f). Pharmacists may continue to dispense medications from legally valid written, oral, or fax prescriptions pursuant to this division.
(j)Notwithstanding any other law, a violation of this section constitutes unprofessional conduct and grounds for disciplinary action by the health care practitioners licensing board.(k)A health care practitioner who fails to meet the electronic capability standards of subdivisions (a) and (b) and who fails to electronically transmit prescriptions as required by subdivision (d) shall be referred to the appropriate state professional licensing board solely for administrative sanctions, as deemed appropriate by that board. This section does not create a private right of action against a health care practitioner. This section does not limit a health care practitioners liability for the negligent failure to diagnose or treat a patient.
(a)On and after January 1, 2020, a health care practitioner authorized to issue a prescription pursuant to Section 4040 shall have the capability to issue an electronic data transmission prescription, as defined under Section 4040, on behalf of a patient and to transmit that electronic data transmission prescription to a pharmacy selected by the patient.
(b)On and after January 1, 2020, a pharmacy, pharmacist, or other practitioner authorized under California law to dispense or furnish a prescription pursuant to Section 4040 shall have the capability to receive an electronic data transmission prescription on behalf of a patient.
(c)For a prescription for a controlled substance, as defined by Section 4021, generation and transmission of the electronic data transmission prescription shall comply with Parts 1300, 1304, 1306, and 1311 of Title 21 of the Code of Federal Regulations, as amended from time to time.
(d)On and after January 1, 2021, a prescription prescribed by a health care practitioner shall be issued as an electronic data transmission prescription. This subdivision shall not apply to prescriptions issued pursuant to subdivision (e).
(e)Subdivision (d) shall not apply to any of the following:
(1)The prescription is issued pursuant to Section 11159.2 of the Health and Safety Code.
(2)An electronic data transmission prescription is not available due to a temporary technological or electrical failure. For purposes of this paragraph, temporary technological or electrical failure means failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified electronic data transmission prescription application used to transmit the prescription.
(3)The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
(4)The prescription is issued by a veterinarian.
(5)The prescription is for eyeglasses or contact lenses.
(5)(6)The prescribing health care practitioner and the dispenser are the same entity.
(6)(7)The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances prescribed by an electronic data transmission prescription in a timely manner, and the delay would adversely impact the patients medical condition.
(8)The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs SCRIPT standard, as amended from time to time.
(f)A health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an electronic data transmission prescription shall document the reason in the patients medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented the electronic data transmission of the prescription.
(g)A pharmacy that receives an electronic data transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient may, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic data transmission prescription to an alternative pharmacy designated by the requester.
(h)If a pharmacy, or its staff, is aware than an attempted transmission of an electronic data transmission prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner.
(i)A pharmacist who receives a written, oral, or faxed prescription shall not be required to verify that the prescription properly falls under one of the exceptions in subdivision (e). Pharmacists may continue to dispense medications from legally valid written, oral, or fax prescriptions pursuant to this division.
(j)Notwithstanding any other law, a violation of this section constitutes unprofessional conduct and grounds for disciplinary action by the health care practitioners licensing board.
(a)On and after January 1, 2020, a health care practitioner authorized to issue a prescription pursuant to Section 4040 shall have the capability to issue an electronic transmission prescription, as defined under Section 4040, on behalf of a patient and to transmit that electronic transmission prescription to a pharmacy selected by the patient.
(b)On and after January 1, 2020, a pharmacy, pharmacist, or other practitioner authorized under California law to dispense or furnish a prescription pursuant to Section 4040 shall have the capability to receive an electronic transmission prescription on behalf of a patient.
(c)For a prescription for a controlled substance, as defined by Section 4021, generation and transmission of the electronic transmission prescription shall comply with Parts 1300, 1304, 1306, and 1311 of Title 21 of the Code of Federal Regulations, as amended from time to time.
(d)On and after January 1, 2021, a prescription prescribed by a health care practitioner shall be issued as an electronic transmission prescription. This subdivision shall not apply to prescriptions issued pursuant to subdivision (e).
(e)Subdivision (d) shall not apply to any of the following:
(1)The prescription is issued pursuant to Section 11159.2 of the Health and Safety Code.
(2)An electronic transmission prescription is not available due to a temporary technological or electrical failure. For purposes of this paragraph, temporary technological or electrical failure means failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified electronic transmission prescription application used to transmit the prescription.
(3)The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
(4)The prescription is issued by a veterinarian.
(5)The prescribing health care practitioner and the dispenser are the same entity.
(6)The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances prescribed by an electronic transmission prescription in a timely manner, and the delay would adversely impact the patients medical condition.
(f)A health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an electronic transmission prescription shall document the reason in the patients medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented the electronic transmission of the prescription.
(g)A pharmacy that receives an electronic transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient may, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic transmission prescription to an alternative pharmacy designated by the requester.
(h)If a pharmacy, or its staff, is aware than an attempted transmission of an electronic transmission prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner.
(i)A pharmacist who receives a written, oral, or faxed prescription shall not be required to verify that the prescription properly falls under one of the exceptions in subdivision (e). Pharmacists may continue to dispense medications from legally valid written, oral, or fax prescriptions pursuant to this division.
(j)Notwithstanding any other law, a violation of this section constitutes unprofessional conduct and grounds for disciplinary action by the health care practitioners licensing board.
|
Date
|
Status
|
|---|---|
| Sep 17, 2018 | Chaptered by Secretary of State - Chapter 438, Statutes of 2018. |
| Sep 17, 2018 | Approved by the Governor. |
| Sep 5, 2018 | Enrolled and presented to the Governor at 3 p.m. |
| Aug 27, 2018 | Senate amendments concurred in. To Engrossing and Enrolling. |
| Aug 22, 2018 | In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 24 pursuant to Assembly Rule 77. |
| Aug 21, 2018 | Read third time. Passed. Ordered to the Assembly. |
| Aug 15, 2018 | Read second time. Ordered to third reading. |
| Aug 14, 2018 | Read third time and amended. Ordered to second reading. |
| Aug 7, 2018 | Read second time. Ordered to third reading. |
| Aug 6, 2018 | From committee: Be ordered to second reading pursuant to Senate Rule 28.8. |
| Jul 3, 2018 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on APPR. |
| Jun 26, 2018 | In committee: Set, first hearing. Hearing canceled at the request of author. |
| Jun 20, 2018 | Read second time and amended. Re-referred to Com. on APPR. |
| Jun 19, 2018 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 7. Noes 1.) (June 18). |
| May 10, 2018 | Referred to Com. on B., P. & E.D. |
| Apr 30, 2018 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Apr 30, 2018 | Read third time. Passed. Ordered to the Senate. |
| Apr 26, 2018 | Read second time. Ordered to third reading. |
| Apr 25, 2018 | From committee: Do pass. (Ayes 13. Noes 2.) (April 25). |
| Apr 10, 2018 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 10. Noes 1.) (April 10). Re-referred to Com. on APPR. |
| Apr 4, 2018 | Re-referred to Com. on B. & P. |
| Apr 3, 2018 | From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended. |
| Mar 8, 2018 | Referred to Com. on B. & P. |
| Feb 17, 2018 | From printer. May be heard in committee March 19. |
| Feb 16, 2018 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 27, 2018 | AB 2789 WOOD Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Aug 21, 2018 | Assembly 3rd Reading AB2789 Wood By Hill | Senate Floor |
Passed |
|
| Jun 18, 2018 | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] | Senate Standing Committee on Business, Professions and Economic Development |
Passed |
|
| Apr 30, 2018 | AB 2789 WOOD Assembly Third Reading | Assembly Floor |
Passed |
|
| Apr 25, 2018 | Do pass. | Assembly Standing Committee on Appropriations |
Passed |
|
| Apr 10, 2018 | Do pass and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Business and Professions |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 2789
Author:(Wood)
As Amended Ver:August 14, 2018
Majority vote
ASSEMBLY: | 61-2 | (April 30, 2018) | SENATE: | 37-1 | (August 21, 2018) |
Original Committee Reference: B. & P.
SUMMARY: Requires that all health care practitioners authorized to issue prescriptions to be capable of electronically prescribing and requires that all prescriptions for controlled substances be transmitted electronically, with exceptions, by January 1, 2022.
The Senate amendments exempt hospital emergency departments or urgent care clinics, as well as health care practitioners and pharmacists providing services to inmates or other individual under the jurisdiction of the Department of Corrections and Rehabilitation, from the electronic prescribing requirement when certain conditions are met; specify that failing to prescribe electronically is subject only to board discipline through imposition of administrative sanctions and not enforceable through a private right of action; and delay implementation.
EXISTING LAW:
- Allows only a physician, dentist, podiatrist, veterinarian, naturopathic doctor, registered nurse, certified nurse-midwife, optometrist, or out-of-state prescriber to write or issue a prescription. (Health and Safety Code (HSC) Section 11150)
- States that a prescription for a controlled substance shall only be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his or her professional practice, and that the responsibility for the proper prescribing and dispensing of controlled substances is upon the prescribing practitioner, but a corresponding responsibility rests with the pharmacist who fills the prescription. (HSC Section 11153)
- Prohibits medical professionals from prescribing, administering, or dispensing a controlled substance to an addict, as defined. (HSC Section 11156)
- Requires that all prescription forms for controlled substance prescriptions be obtained from security printers approved by the Department of Justice (DOJ) and sets a number of parameters for the DOJ's approval process. (HSC Section 11161.5)
- Provides that when a prescriber's authority to prescribe controlled substances is restricted, the law enforcement agency or licensing board that sought the restrictions shall provide the prescriber's name, category of licensure, license number, and the nature of the restrictions imposed on the prescriber to security printers, the DOJ, and the Board of Pharmacy. (HSC Section 11161.7)
- Lists a number of required features that must be included for all prescription forms for controlled substances, including fraud-prevention identifiers, printing information, and information relating to the prescribing practitioner. (HSC Section 11162.1)
- Criminalizes the counterfeiting of prescription pads and the possession of counterfeit prescription pads. (HSC Sections 11162.5-11162.6)
- Enables security printers and prescribers to report stolen or lost prescription pads to the DOJ through the Controlled Substance Utilization Review and Evaluation System (CURES). (HSC Section 11165.3)
- Requires all prescriptions and dispensations of controlled substances to meet a series of requirements including use of a controlled substance prescription form, presence of a signature and date in ink, and the address of the patient. (HSC Section 11164)
- Prohibits any person from obtaining or attempting to obtain a prescription for controlled substances, by fraud, deceit, misrepresentation, subterfuge, or the concealment of a material fact. (HSC Section 11173)
- Defines "electronic data transmission prescription" as any prescription order, other than a facsimile, that is electronically transmitted from a licensed prescriber to a pharmacy. (Business and Professions Code (BPC) Section 4040)
FISCAL EFFECT: According to the Senate Appropriations Committee, pursuant to Senate Rule 28.8, negligible state costs.
COMMENTS:
Purpose. This bill is sponsored by the author. According to the author:
Health care is becoming more and more complex. Electronic Health Records are becoming the norm. The ever increasing reporting requirements to CURES for controlled substances, the proliferation of more and new drugs, the increased numbers of prescriptions written annually, the increase in total numbers of prescriptions individuals are receiving, the risk of errors, the ongoing issue of fraudulent prescriptions and the diversion of prescription medicines into street drugs with oftentimes deadly results all point to the need for electronic prescribing of drugs.
A study conducted at a Johns Hopkins Medication outpatient pharmacy reported that 89% of handwritten prescriptions failed to meet best practice guidelines or were missing information that would otherwise be prompted by an e-prescribing system. By comparison, not a single prescription issued electronically in that study contained these types of errors. E-prescribing would address several of the issues identified with the existing prescription requirements.
Adoption of technology to improve patient outcomes has always been a hallmark of the medical profession and the adoption of e-prescribing is no exception.
Background.
Overview of the Opioid Crisis. In October of 2017, the White House declared the opioid crisis a public health emergency, formally recognizing what had long been understood to be a growing epidemic responsible for devastation in communities across the country. According to the Centers for Disease Control and Prevention, as many as 50,000 Americans died of an opioid overdose in 2016, representing a 28% increase over the previous year. Additionally, the number of Americans who died of an overdose of fentanyl and other opioids more than doubled during that time with nearly 20,000 deaths. These death rates compare to, and potentially exceed, those at the height of the acquired immunodeficiency syndrome (AIDS) epidemic.
Electronic Prescribing. Many public health advocates have long championed electronic prescribing (or "e-prescribing") as one of the most effective ways to combat prescription fraud and drug diversion. Studies dating as far back as 2000 recommended phasing out paper prescription pads in favor of mandatory e-prescribing. A cultural inertia in regards to technology that persists in the medical profession, combined with concerns about whether a sufficient number of practitioners' offices are technologically sophisticated enough to adapt to a mandate, has traditionally represented a strong barrier to any institutionalized change. This has remained relatively true even as electronic health records, specialized smartphone apps, and broadband internet access continue to become commonplace in the medical profession.
In 2008, the California Health Care Foundation issued a report entitled The Outlook for Electronic Prescribing in California, which stated that only 1.2% of prescriptions filled by California's community pharmacies were sent electronically. The report blamed cost, legal restrictions, and technology fees for the slow adoption rate. That same year, the United States Congress passed the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA), which incentivized e-prescribing among practitioners and providers and penalized those who did not adopt the technology within a few years.
Six other states have successfully mandated e-prescribing: Connecticut, Maine, North Carolina, New York, Rhode Island, and Virginia. Efforts to pass a federal mandate through the United States Congress continue with the introduction of the Every Prescription Conveyed Securely Act by Reps. Clark and Mullin, which would mandate e-prescribing for all Medicare Part D transactions by 2020. This federal legislation is supported by major retail pharmacies like CVS Health and Walgreens.
In a 2016 report, Surescripts, a health information network, stated that an estimated 73% of all prescriptions in the United States are now completed electronically. However, this number is only 14% of prescriptions for controlled substances. Implementing mandatory electronic transmission of prescriptions in California would represent significant progress for those in support of promoting the e-prescribing nationally.
Analysis Prepared by: Robert Sumner / B. & P. / (916) 319-3301 FN: 0004050
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB |
THIRD READING
Bill No: AB 2789
:
SENATE BUS., PROF. & ECON. DEV. COMMITTEE: 7-1, 6/18/18
AYES: Hill, Allen, Dodd, Galgiani, Glazer, Hernandez, Wilk
NOES: Fuller
NO VOTE RECORDED: Pan
SENATE APPROPRIATIONS COMMITTEE: Senate Rule 28.8
ASSEMBLY FLOOR: 61-2, 4/30/18 - See last page for vote
SUBJECT: Health care practitioners: prescriptions: electronic data transmission
DIGEST:
This bill requires health care practitioners authorized have the capability to issue electronic prescriptions by January 1, 2020, and requires that all prescriptions for controlled substances be transmitted electronically beginning January 1, 2021.
Senate Floor Amendments of 8/14/18 exempt health care practitioners, pharmacists, or pharmacies providing health care services to an inmate, individual on parole, or youth under the jurisdiction of the Department of Corrections and Rehabilitation from the provisions of the bill.
Existing law:
- Specifies certain requirements regarding the dispensing and furnishing of dangerous drugs and devices, and prohibits a person from furnishing any dangerous drug or device except upon the prescription of a physician, dentist, podiatrist, optometrist, veterinarian or naturopathic doctor (ND). (BPC § 4059)
- Prohibits any person other than a physician, dentist, podiatrist, veterinarian, ND (according to certain supervision and protocol requirements), pharmacist (according to certain authorization and according to certain policies and procedures), certified nurse midwife (CNM) (if furnished or ordered incidentally to the provision of family planning services, routine health care or perinatal care, or care rendered consistent with the CNM’s practice; occurs under physician and surgeon supervision; and is in accordance with standardized procedures or protocols as specified), nurse practitioner (NP) (if it is consistent with a NP’s educational preparation or for which clinical competency has been established and maintained; occurs under physician and surgeon supervision; and is in accordance with standardized procedures or protocols as specified); a pharmacist or registered nurse or physician assistant acting within the scope of an experimental health workforce project authorized by the Office of Statewide Health Planning and Development (HSC §§ 128125 et seq.); an optometrist licensed under the Optometry Practice Act, or an out-of-state prescriber acting in an emergency situation from writing or issuing a prescription for a controlled substance. (HSC § 11150)
This bill:
- Requires, on and after January 1, 2022, a health care practitioner authorized to issue a prescription to have the capability to issue an e-prescription to transmit that e-prescription to a pharmacy selected by the patient. On and after January 1, 2022, requires a pharmacy, pharmacist, or other practitioner authorized to dispense or furnish a prescription to have the capability to receive an e-prescription.
- Requires, on and after January 1, 2022, a prescription prescribed by a health care practitioner to be issued as an e-prescription. Makes the following exceptions to this requirement:
- Controlled substances prescriptions for use by a patient who has a terminal illness.
- E-prescribing is not available due to a temporary technological or electrical failure, defined as failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified e-prescription application used to transmit the prescription.
- The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
- The prescription is issued in a hospital emergency department or urgent care clinic and either the patient resides outside California, the patient resides outside the geographic area of the hospital, the patient is homeless or indigent and does not have a preferred pharmacy or, the prescription is issued at a time when a patient’s regular or preferred pharmacy is likely to be closed. Under any of these conditions, a prescription shall be electronically issued but does not require electronic transmission and may be provided directly to the patient.
- The prescription is issued by a veterinarian.
- The prescription is for eyeglasses or contact lenses.
- The prescribing health care practitioner and the dispenser are the same entity.
- The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances from an e-prescription in a timely manner, and the delay would adversely impact the patient’s medical condition.
- The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs’ SCRIPT standard, as amended from time to time.
- Requires a health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an e-prescription to document the reason in the patient’s medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented e-prescribing.
- Authorizes a pharmacy that receives an e-prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient to, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the
e-prescription to an alternative pharmacy designated by the requester. - Specifies that if a pharmacy is aware than an attempted e-prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner. Clarifies that a pharmacist who receives a written, oral, or faxed prescription is not required to verify that the prescription properly falls under one of the exceptions outlined in this bill.
- Specifies that a violation of these provisions by a health care practitioner, pharmacist or pharmacy shall be referred to the appropriate state professional licensing board solely for administrative sanctions, as deemed appropriate by that board. This bill does not create a private right of action against a health care practitioner. This bill does not limit a health care practitioner’s liability for the negligent failure to diagnose or treat a patient.
- Exempts health care practitioners, pharmacists, or pharmacies providing health care services to an inmate, individual on parole, or youth under the jurisdiction of the Department of Corrections and Rehabilitation from the provisions of this bill.
Background
Prescriptions and e-prescribing. Electronic prescribing is lauded as a key component in the future of health care. Efforts have been underway at the state and federal level to modernize systems while enhancing the quality of care, raising levels of patient safety and realizing cost savings. In 2004, the President announced a plan to ensure that electronic health records were available to most Americans by 2014, and key components of the federal American Reinvestment and Recovery Act were designed to promote the expansion of health information technology initiatives. Streamlining the practice of medicine to be more efficient through tools such as electronic prescribing and electronic health care records has the potential to, among other benefits, minimize dangerous prescription errors.
Six other states have successfully mandated e-prescribing: Connecticut, Maine, North Carolina, New York, Rhode Island, and Virginia. Efforts to pass a federal mandate through the United States Congress continue with the introduction of the Every Prescription Conveyed Securely Act by Reps. Clark and Mullin, which would mandate e-prescribing for all Medicare Part D transactions by 2020. This federal legislation is supported by major retail pharmacies like CVS Health and Walgreens.
In a 2016 report, Surescripts, a health information network, stated that an estimated 73 percent of all prescriptions in the United States are now completed electronically. However, this number is only 14 percent of prescriptions for controlled substances. Implementing mandatory electronic transmission of prescriptions in California would represent significant progress for those in support of promoting the e-prescribing nationally.
Controlled substances. In 2010, the federal Drug Enforcement Administration (DEA) revised regulations to provide health care practitioners with the option of issuing e-prescriptions for controlled substances. The regulations also permit pharmacies to receive, dispense, and archive e-prescriptions. Under the DEA rules, prescribing practitioners are still able to write, and manually sign, prescriptions for schedule II, III, IV, and V controlled substances and pharmacies are still able to dispense controlled substances based on those written prescriptions. Oral prescriptions remain valid for schedule III, IV, and V controlled substances. E-prescriptions for controlled substances are only permissible if the electronic prescription and the pharmacy application meet DEA's requirements, including identity proofing of individual prescribing practitioners, two-factor authentication credentials and access controls. The DEA regulations specify that e-prescriptions for controlled substances may be subject to state laws and regulations but note that if state requirements are more stringent than DEA's regulations, the state requirements would supersede any less stringent DEA provision.
Comments
According to the author, “California and the nation are experiencing an opioid epidemic. For the 24 month period July 2015 through July 2017, 9,490 Californians lost their lives as a result of drug overdoses, a trend primarily driven by opioids including heroin and fentanyl. California ranks in the top five states when it comes to the raw number of drug-overdose deaths. Enough prescription opioids are prescribed every year to kill every Californian more than twice. Further, in some counties, more opioid related prescriptions are written than there are people in the county. The sheer number of opioid prescriptions written lends itself to the conclusion that many of these prescriptions may be obtained through fraudulent means such as doctor shopping, stolen or forged prescription pads, and the altering of legitimate prescriptions to increase quantity and or frequency of refills.”
The author states that e-prescribing for controlled substances would “significantly reduce, if not eliminate paper-based fraud and forgery while creating electronic records of controlled substance transactions, thereby strengthening surveillance and drug monitoring programs in California. Electronic controlled substance prescriptions cannot be altered or copied and are electronically trackable.”
Nine states have now passed e-prescribing laws for controlled substances and
17 states, including California, have laws pending. States with existing laws include large states like New York and smaller, rural states such as Maine and Rhode Island.
In addition to the issue of fraudulent prescriptions, a 2017 report from the US Department of Health and Human Services’ Agency for Healthcare Research and Quality stated that prescription medication use is “widespread, complex, and increasingly risky”. Clinicians have access to thousands upon thousands of prescription medications and nearly one-third of adults in the United States take five or more medications. According to a July 2017 study published in the journal Clinical Toxicology, more than 1.3 million people are injured by medication errors annually in the United States. According to the same report, most of the mistakes were preventable.
A study conducted at a Johns Hopkins Medication outpatient pharmacy reported that 89% of handwritten prescriptions failed to meet best practice guidelines or were missing information that would otherwise be prompted by an e-prescribing system. By comparison, not a single prescription issued electronically in that study contained these types of errors. E-prescribing would significantly reduce medication errors.
FISCAL EFFECT: Appropriation: Fiscal Com.: Local:
America’s Physician Groups
California Association of Health Underwriters
California Dental Association
California Pharmacists Association
California Retailers Association
California State Board of Pharmacy
Healthcare Distribution Alliance
McKesson
Medical Board of California
National Association of Chain Drug Stores
OCHIN
OPPOSITION: (Verified 8/15/18)
California Academy of Family Physicians
California Medical Association
California Society of Plastic Surgeons
Osteopathic Physicians and Surgeons of California
ARGUMENTS IN SUPPORT: The California Association of Health Underwriters believes that this bill will decrease the associated high costs of prescription drugs on healthcare premiums and will improve safety and quality of life.
The California Pharmacists Association (CPhA) writes in support, “CPhA has a long-standing policy to support the use of electronic methods for the transmittal of prescriptions and other patient care information provided that adequate safeguards are in place to prevent and detect inappropriate or unauthorized transmittals.” “Technology is a key component pf the current healthcare system, improving patient outcomes. We see e-prescribing as part of this evolution.”
OCHIN writes in support, “Electronic controlled substance prescriptions cannot be altered, cannot be copied and are electronically trackable.”
ARGUMENTS IN OPPOSITION: The California Society of Plastic Surgeons writes in opposition, “Like many physicians’ offices, the vast majority of plastic surgery practices are organized as small or solo physician practices. The cost for electronic medical records (EMR) systems which would also allow for electronic prescribing is significant to these small practices.”
The California Medical Association (CMA) and the California Academy of Family Physicians (CAFP) are opposed unless amended and request amendments to extend the implementation deadline and exempt certain practices. According to CMA, “only 21 percent of physicians have adopted electronic prescribing for controlled substances (EPCS) through the DEA because the DEA system is antiquated, costly, and burdensome. Physicians, particularly those in small and rural practices, have experienced major difficulties with the DEA requirements and therefore, physicians’ ability to e-prescribe controlled substances has been dramatically lower than general e-prescribing. An EPCS mandate would unnecessarily require physicians to absorb significant additional costs. It is an unfunded mandate on physicians. It would create an enormous regulatory burden on resource-strapped small and rural practices, which would force them to stop prescribing altogether and patients with legitimate needs would not be served. Patients in need of appropriate pain care would suffer. Instead, the Legislature should focus on urging the DEA update and reduce the burdensome process by a date certain. The DEA’s technology is so outdated it cannot even recognize Apple products or fingerprinting scanners commonly used in banking and electronic medical records. Physicians are forced to purchase additional systems from the few monopolistic vendors approved by the DEA that are not integrated with physicians’ other systems – such as their Electronic Health Record. The problems with the DEA system have been well documented.
“CAFP is also asking for a ‘retirement exemption’ to exempt physicians within a short time of retirement; an exemption of smaller physician practices, including those in rural communities and solo practices, who do not have the prescription volume to justify the cost of a new e-prescribing system; a cost exemption for providers who may suffer a financial hardship by implementing the new e-prescribing system and an amendment to remove the language stating that it is ‘unprofessional conduct’ for noncompliance of any provision of this bill.”
According to the Osteopathic Physicians and Surgeons of California, more time is needed to allow physicians and other prescribers to ensure they are compliant with this bill and argues that small practices with few physicians and rural practices without access to e-prescribing technology or adequate Internet connectivity may be perpetually unable to comply, or exposed to undue hardship by attempting to comply.
ASSEMBLY FLOOR: 61-2, 4/30/18
AYES: Acosta, Aguiar-Curry, Arambula, Baker, Berman, Bloom, Bonta, Burke, Caballero, Calderon, Carrillo, Cervantes, Chau, Chávez, Chiu, Chu, Cooley, Cunningham, Daly, Eggman, Frazier, Friedman, Eduardo Garcia, Gipson, Gloria, Gonzalez Fletcher, Gray, Grayson, Holden, Irwin, Jones-Sawyer, Kalra, Kamlager-Dove, Kiley, Lackey, Levine, Limón, Low, Maienschein, Mathis, McCarty, Melendez, Mullin, Nazarian, Obernolte, O'Donnell, Quirk, Quirk-Silva, Reyes, Rodriguez, Rubio, Salas, Santiago, Steinorth, Mark Stone, Thurmond, Ting, Waldron, Weber, Wood, Rendon
NOES: Travis Allen, Harper
NO VOTE RECORDED: Bigelow, Brough, Chen, Choi, Cooper, Dahle, Flora, Fong, Gallagher, Cristina Garcia, Mayes, Medina, Muratsuchi, Patterson, Voepel
8/15/18 14:14:57
**** END ****
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB |
THIRD READING
Bill No: AB 2789
:
SENATE BUS., PROF. & ECON. DEV. COMMITTEE: 7-1, 6/18/18
AYES: Hill, Allen, Dodd, Galgiani, Glazer, Hernandez, Wilk
NOES: Fuller
NO VOTE RECORDED: Pan
SENATE APPROPRIATIONS COMMITTEE: Senate Rule 28.8
ASSEMBLY FLOOR: 61-2, 4/30/18 - See last page for vote
DIGEST:
This bill requires health care practitioners authorized have the capability to issue electronic prescriptions by January 1, 2020, and requires that all prescriptions for controlled substances be transmitted electronically beginning January 1, 2021.
Existing law:
- Specifies certain requirements regarding the dispensing and furnishing of dangerous drugs and devices, and prohibits a person from furnishing any dangerous drug or device except upon the prescription of a physician, dentist, podiatrist, optometrist, veterinarian or naturopathic doctor (ND). (BPC § 4059)
- Prohibits any person other than a physician, dentist, podiatrist, veterinarian, ND (according to certain supervision and protocol requirements), pharmacist (according to certain authorization and according to certain policies and procedures), certified nurse midwife (CNM) (if furnished or ordered incidentally to the provision of family planning services, routine health care or perinatal care, or care rendered consistent with the CNM’s practice; occurs under physician and surgeon supervision; and is in accordance with standardized procedures or protocols as specified), nurse practitioner (NP) (if it is consistent with a NP’s educational preparation or for which clinical competency has been established and maintained; occurs under physician and surgeon supervision; and is in accordance with standardized procedures or protocols as specified); a pharmacist or registered nurse or physician assistant acting within the scope of an experimental health workforce project authorized by the Office of Statewide Health Planning and Development (HSC §§ 128125 et seq.); an optometrist licensed under the Optometry Practice Act, or an out-of-state prescriber acting in an emergency situation from writing or issuing a prescription for a controlled substance. (HSC § 11150)
This bill:
- Requires, on and after January 1, 2022, a health care practitioner authorized to issue a prescription to have the capability to issue an e-prescription to transmit that e-prescription to a pharmacy selected by the patient. On and after January 1, 2022, requires a pharmacy, pharmacist, or other practitioner authorized to dispense or furnish a prescription to have the capability to receive an e-prescription.
- Requires, on and after January 1, 2022, a prescription prescribed by a health care practitioner to be issued as an e-prescription. Makes the following exceptions to this requirement:
- Controlled substances prescriptions for use by a patient who has a terminal illness.
- E-prescribing is not available due to a temporary technological or electrical failure, defined as failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified e-prescription application used to transmit the prescription.
- The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
- The prescription is issued in a hospital emergency department or urgent care clinic and either the patient resides outside California, the patient resides outside the geographic area of the hospital, the patient is homeless or indigent and does not have a preferred pharmacy or, the prescription is issued at a time when a patient’s regular or preferred pharmacy is likely to be closed. Under any of these conditions, a prescription shall be electronically issued but does not require electronic transmission and may be provided directly to the patient.
- The prescription is issued by a veterinarian.
- The prescription is for eyeglasses or contact lenses.
- The prescribing health care practitioner and the dispenser are the same entity.
- The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances from an e-prescription in a timely manner, and the delay would adversely impact the patient’s medical condition.
- The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs’ SCRIPT standard, as amended from time to time.
- Requires a health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an e-prescription to document the reason in the patient’s medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented e-prescribing.
- Authorizes a pharmacy that receives an e-prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient to, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the
e-prescription to an alternative pharmacy designated by the requester. - Specifies that if a pharmacy is aware than an attempted e-prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner. Clarifies that a pharmacist who receives a written, oral, or faxed prescription is not required to verify that the prescription properly falls under one of the exceptions outlined in this bill.
- Specifies that a violation of these provisions by a health care practitioner, pharmacist or pharmacy shall be referred to the appropriate state professional licensing board solely for administrative sanctions, as deemed appropriate by that board. This bill does not create a private right of action against a health care practitioner. This bill does not limit a health care practitioner’s liability for the negligent failure to diagnose or treat a patient.
Background
Prescriptions and e-prescribing. Electronic prescribing is lauded as a key component in the future of health care. Efforts have been underway at the state and federal level to modernize systems while enhancing the quality of care, raising levels of patient safety and realizing cost savings. In 2004, the President announced a plan to ensure that electronic health records were available to most Americans by 2014, and key components of the federal American Reinvestment and Recovery Act were designed to promote the expansion of health information technology initiatives. Streamlining the practice of medicine to be more efficient through tools such as electronic prescribing and electronic health care records has the potential to, among other benefits, minimize dangerous prescription errors.
Six other states have successfully mandated e-prescribing: Connecticut, Maine, North Carolina, New York, Rhode Island, and Virginia. Efforts to pass a federal mandate through the United States Congress continue with the introduction of the Every Prescription Conveyed Securely Act by Reps. Clark and Mullin, which would mandate e-prescribing for all Medicare Part D transactions by 2020. This federal legislation is supported by major retail pharmacies like CVS Health and Walgreens.
In a 2016 report, Surescripts, a health information network, stated that an estimated 73 percent of all prescriptions in the United States are now completed electronically. However, this number is only 14 percent of prescriptions for controlled substances. Implementing mandatory electronic transmission of prescriptions in California would represent significant progress for those in support of promoting the e-prescribing nationally.
Controlled substances. In 2010, the federal Drug Enforcement Administration (DEA) revised regulations to provide health care practitioners with the option of issuing e-prescriptions for controlled substances. The regulations also permit pharmacies to receive, dispense, and archive e-prescriptions. Under the DEA rules, prescribing practitioners are still able to write, and manually sign, prescriptions for schedule II, III, IV, and V controlled substances and pharmacies are still able to dispense controlled substances based on those written prescriptions. Oral prescriptions remain valid for schedule III, IV, and V controlled substances. E-prescriptions for controlled substances are only permissible if the electronic prescription and the pharmacy application meet DEA's requirements, including identity proofing of individual prescribing practitioners, two-factor authentication credentials and access controls. The DEA regulations specify that e-prescriptions for controlled substances may be subject to state laws and regulations but note that if state requirements are more stringent than DEA's regulations, the state requirements would supersede any less stringent DEA provision.
Comments
According to the author, “California and the nation are experiencing an opioid epidemic. For the 24 month period July 2015 through July 2017, 9,490 Californians lost their lives as a result of drug overdoses, a trend primarily driven by opioids including heroin and fentanyl. California ranks in the top five states when it comes to the raw number of drug-overdose deaths. Enough prescription opioids are prescribed every year to kill every Californian more than twice. Further, in some counties, more opioid related prescriptions are written than there are people in the county. The sheer number of opioid prescriptions written lends itself to the conclusion that many of these prescriptions may be obtained through fraudulent means such as doctor shopping, stolen or forged prescription pads, and the altering of legitimate prescriptions to increase quantity and or frequency of refills.”
The author states that e-prescribing for controlled substances would “significantly reduce, if not eliminate paper-based fraud and forgery while creating electronic records of controlled substance transactions, thereby strengthening surveillance and drug monitoring programs in California. Electronic controlled substance prescriptions cannot be altered or copied and are electronically trackable.”
Nine states have now passed e-prescribing laws for controlled substances and
17 states, including California, have laws pending. States with existing laws include large states like New York and smaller, rural states such as Maine and Rhode Island.
In addition to the issue of fraudulent prescriptions, a 2017 report from the US Department of Health and Human Services’ Agency for Healthcare Research and Quality stated that prescription medication use is “widespread, complex, and increasingly risky”. Clinicians have access to thousands upon thousands of prescription medications and nearly one-third of adults in the United States take five or more medications. According to a July 2017 study published in the journal Clinical Toxicology, more than 1.3 million people are injured by medication errors annually in the United States. According to the same report, most of the mistakes were preventable.
A study conducted at a Johns Hopkins Medication outpatient pharmacy reported that 89% of handwritten prescriptions failed to meet best practice guidelines or were missing information that would otherwise be prompted by an e-prescribing system. By comparison, not a single prescription issued electronically in that study contained these types of errors. E-prescribing would significantly reduce medication errors.
FISCAL EFFECT: Appropriation: Fiscal Com.: Local:
America’s Physician Groups
California Association of Health Underwriters
California Dental Association
California Pharmacists Association
California Retailers Association
California State Board of Pharmacy
Healthcare Distribution Alliance
McKesson
Medical Board of California
National Association of Chain Drug Stores
OCHIN
California Academy of Family Physicians
California Medical Association
California Society of Plastic Surgeons
Osteopathic Physicians and Surgeons of California
ARGUMENTS IN SUPPORT: The California Association of Health Underwriters believes that this bill will decrease the associated high costs of prescription drugs on healthcare premiums and will improve safety and quality of life.
The California Pharmacists Association (CPhA) writes in support, “CPhA has a long-standing policy to support the use of electronic methods for the transmittal of prescriptions and other patient care information provided that adequate safeguards are in place to prevent and detect inappropriate or unauthorized transmittals.” “Technology is a key component pf the current healthcare system, improving patient outcomes. We see e-prescribing as part of this evolution.”
OCHIN writes in support, “Electronic controlled substance prescriptions cannot be altered, cannot be copied and are electronically trackable.”
ARGUMENTS IN OPPOSITION: The California Society of Plastic Surgeons writes in opposition, “Like many physicians’ offices, the vast majority of plastic surgery practices are organized as small or solo physician practices. The cost for electronic medical records (EMR) systems which would also allow for electronic prescribing is significant to these small practices.”
The California Medical Association (CMA) and the California Academy of Family Physicians (CAFP) are opposed unless amended and request amendments to extend the implementation deadline and exempt certain practices. According to CMA, “only 21 percent of physicians have adopted electronic prescribing for controlled substances (EPCS) through the DEA because the DEA system is antiquated, costly, and burdensome. Physicians, particularly those in small and rural practices, have experienced major difficulties with the DEA requirements and therefore, physicians’ ability to e-prescribe controlled substances has been dramatically lower than general e-prescribing. An EPCS mandate would unnecessarily require physicians to absorb significant additional costs. It is an unfunded mandate on physicians. It would create an enormous regulatory burden on resource-strapped small and rural practices, which would force them to stop prescribing altogether and patients with legitimate needs would not be served. Patients in need of appropriate pain care would suffer. Instead, the Legislature should focus on urging the DEA update and reduce the burdensome process by a date certain. The DEA’s technology is so outdated it cannot even recognize Apple products or fingerprinting scanners commonly used in banking and electronic medical records. Physicians are forced to purchase additional systems from the few monopolistic vendors approved by the DEA that are not integrated with physicians’ other systems – such as their Electronic Health Record. The problems with the DEA system have been well documented.
“CAFP is also asking for a ‘retirement exemption’ to exempt physicians within a short time of retirement; an exemption of smaller physician practices, including those in rural communities and solo practices, who do not have the prescription volume to justify the cost of a new e-prescribing system; a cost exemption for providers who may suffer a financial hardship by implementing the new e-prescribing system and an amendment to remove the language stating that it is ‘unprofessional conduct’ for noncompliance of any provision of this bill.”
According to the Osteopathic Physicians and Surgeons of California, more time is needed to allow physicians and other prescribers to ensure they are compliant with this bill and argues that small practices with few physicians and rural practices without access to e-prescribing technology or adequate Internet connectivity may be perpetually unable to comply, or exposed to undue hardship by attempting to comply.
ASSEMBLY FLOOR: 61-2, 4/30/18
AYES: Acosta, Aguiar-Curry, Arambula, Baker, Berman, Bloom, Bonta, Burke, Caballero, Calderon, Carrillo, Cervantes, Chau, Chávez, Chiu, Chu, Cooley, Cunningham, Daly, Eggman, Frazier, Friedman, Eduardo Garcia, Gipson, Gloria, Gonzalez Fletcher, Gray, Grayson, Holden, Irwin, Jones-Sawyer, Kalra, Kamlager-Dove, Kiley, Lackey, Levine, Limón, Low, Maienschein, Mathis, McCarty, Melendez, Mullin, Nazarian, Obernolte, O'Donnell, Quirk, Quirk-Silva, Reyes, Rodriguez, Rubio, Salas, Santiago, Steinorth, Mark Stone, Thurmond, Ting, Waldron, Weber, Wood, Rendon
NOES: Travis Allen, Harper
NO VOTE RECORDED: Bigelow, Brough, Chen, Choi, Cooper, Dahle, Flora, Fong, Gallagher, Cristina Garcia, Mayes, Medina, Muratsuchi, Patterson, Voepel
8/8/18 18:27:16
**** END ****
SENATE COMMITTEE ON
BUSINESS, PROFESSIONS AND ECONOMIC DEVELOPMENT
Senator Jerry Hill, Chair
2017 - 2018 Regular
Bill No: Hearing Date: June 18, 2018
Author: | |||
Version: | April 3, 2018 | ||
Urgency: | No | Fiscal: | Yes |
Consultant: | Sarah Mason | ||
Subject:
SUMMARY: Requires health care practitioners authorized have the capability to issue electronic prescriptions by January 1, 2020 and requires that all prescriptions for controlled substances be transmitted electronically beginning January 1, 2021.
Existing law:
- Establishes various practice acts in the Business and Professions Code (BPC) governed by various boards within the Department of Consumer Affairs (DCA) which provide for the licensing and regulation of health care professionals including: physicians and surgeons (under the Medical Practice Act), dentists (under the Dental Practice Act), veterinarians (under the Veterinary Medicine Practice Act); registered nurses, nurse practitioners (NP) and certified nurse-midwives (CNM) (under the Nursing Practice Act); physician assistants (PA) (under the Physician Assistant Practice Act); osteopathic physicians and surgeons (under the Osteopathic Medical Practice Act); naturopathic doctors (ND) (under the Naturopathic Doctors Act); optometrists (under the Optometry Practice Act); doctors of podiatric medicine (under the Podiatric Act) and; pharmacies, pharmacists and wholesalers of dangerous drugs or devices (under the Pharmacy Law). (Business and Professions Code (BPC) § 500 et seq.)
- Defines “prescription” as an oral, written, or electronic transmission order that is both given individually for the person or persons for whom ordered that includes specified information and is issued by an authorized health care practitioner.
(BPC § 4040) - Defines “Electronic transmission prescription” (e-prescription) as both image and data prescriptions and any prescription order for which a facsimile of the order is received by a pharmacy from a licensed prescriber and any prescription order, other than an electronic image transmission prescription, that is electronically transmitted from a licensed prescriber to a pharmacy. (Id.)
- Specifies certain requirements regarding the dispensing and furnishing of dangerous drugs and devices, and prohibits a person from furnishing any dangerous drug or device except upon the prescription of a physician, dentist, podiatrist, optometrist, veterinarian or ND. (BPC § 4059)
- Establishes the Uniform Controlled Substances Act which regulates controlled substances and defines an opiate as any substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having addiction-forming or addiction-sustaining liability. (Health and Safety Code (HSC) § 11020)
- Classifies controlled substances into five schedules according to their danger and potential for abuse. (HSC §§ 11054-11058)
- Prohibits any person other than a physician, dentist, podiatrist, veterinarian, ND (according to certain supervision and protocol requirements), pharmacist (according to certain authorization and according to certain policies and procedures), CNM (if furnished or ordered incidentally to the provision of family planning services, routine health care or perinatal care, or care rendered consistent with the CNM’s practice; occurs under physician and surgeon supervision; and is in accordance with standardized procedures or protocols as specified), NP (if it is consistent with a NP’s educational preparation or for which clinical competency has been established and maintained; occurs under physician and surgeon supervision; and is in accordance with standardized procedures or protocols as specified); a pharmacist or registered nurse or PA acting within the scope of an experimental health workforce project authorized by the Office of Statewide Health Planning and Development (HSC §§ 128125 et seq.); an optometrist licensed under the Optometry Practice Act, or an out-of-state prescriber acting in an emergency situation from writing or issuing a prescription for a controlled substance.
(HSC § 11150) - Requires that all prescription forms for controlled substance prescriptions be obtained from security printers approved by the DOJ and sets a number of parameters for the DOJ’s approval process. (HSC § 11161.5)
- Establishes CURES for the electronic monitoring of Schedule II, III and IV controlled substance prescriptions. CURES provides for the electronic transmission of Schedule II, III and IV controlled substance prescription information to the Department of Justice (DOJ) no more than seven days from the time prescriptions are dispensed. (HSC § 11165)
- States that the purpose of CURES is to assist law enforcement and regulatory agencies in controlling diversion and abuse of Schedule II, III and IV controlled substances and for statistical analysis, education and research. (HSC § 11165 (a))
- Establishes privacy protections for patient data and specifies that the operation of CURES shall comply with all applicable federal and state privacy and security laws and regulations. Specifies that CURES shall operate under existing provisions of law to safeguard the privacy and confidentiality of patients. Specifies that data obtained from CURES can only be accessed by appropriate state, local and federal persons or public agencies for disciplinary, civil or criminal actions. Specifies that CURES data shall also only be provided, as determined by DOJ, to other agencies or entities for educating practitioners and others, in lieu of disciplinary, civil or criminal actions. Authorizes non-identifying CURES data to be provided to public and private entities for education, research, peer review and statistical analysis. Requires DOJ to establish policies, procedures and regulations regarding the use, access, evaluation, management, implementation, operation, storage, disclosure, and security of the information within CURES. (HSC § 11165 (c) (1) and (c) (2) (A))
- Requires DOJ to upgrade CURES to allow health information technology systems that meet certain patient privacy and data security requirements to interoperate with the database, allowing prescribers and dispensers to make queries through their electronic health record applications. (HSC § 11165.1)
- Requires health care practitioners in receipt of a federal Drug Enforcement Administration (DEA) registration providing authorization to prescribe controlled substances, as well as pharmacists, to register for access to the CURES database. (HSC § 11165.1(a))
- Enables security printers and prescribers to report stolen or lost prescription pads to the DOJ through CURES. (HSC § 11165.3)
- Prohibits any person from obtaining or attempting to obtain a prescription for controlled substances, by fraud, deceit, misrepresentation, subterfuge, or the concealment of a material fact. (HSC § 11173)
This bill:
- On and after January 1, 2020, requires a health care practitioner authorized to issue a prescription to have the capability to issue an e-prescription to transmit that e-prescription to a pharmacy selected by the patient.
- On and after January 1, 2020, requires a pharmacy, pharmacist, or other practitioner authorized to dispense or furnish a prescription to have the capability to receive an e-prescription.
- Specifies that e-prescriptions for controlled substances shall comply with the Drug Enforcement Administration’s (DEA) rule “Electronic Prescriptions for Controlled Substances", which became effective in 2010, as amended from time to time.
- On and after January 1, 2021, requires a prescription prescribed by a health care practitioner to be issued as an e-prescription. Makes the following exceptions to this requirement:
- Controlled substances prescriptions for use by a patient who has a terminal illness.
- E-prescribing is not available due to a temporary technological or electrical failure, defined as failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified e-prescription application used to transmit the prescription.
- The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
- The prescription is issued by a veterinarian.
- The prescription is for eyeglasses or contact lenses.
- The prescribing health care practitioner and the dispenser are the same entity.
- The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances from an e-prescription in a timely manner, and the delay would adversely impact the patient’s medical condition.
- The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs’ SCRIPT standard, as amended from time to time.
- Requires a health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an e-prescription to document the reason in the patient’s medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented
e-prescribing. - Authorizes a pharmacy that receives an e-prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient to, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the
e-prescription to an alternative pharmacy designated by the requester. - Specifies that if a pharmacy is aware than an attempted e-prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner. Clarifies that a pharmacist who receives a written, oral, or faxed prescription is not required to verify that the prescription properly falls under one of the exceptions outlined in this bill.
- Makes a violation of these provisions unprofessional conduct and grounds for disciplinary action by the health care practitioner’s licensing board.
FISCAL EFFECT: This bill is keyed fiscal by Legislative Counsel. According to the Assembly Committee on Appropriations analysis dated April 25, 2018, this bill will result in minor and absorbable costs to the Board of Pharmacy and Medical Board of California to create new codes in relevant information technology systems to track violations.
COMMENTS:
- Purpose. The Author is the Sponsor of this bill. According to the Author, “California and the nation are experiencing an opioid epidemic. For the 24 month period July 2015 through July 2017, 9,490 Californians lost their lives as a result of drug overdoses, a trend primarily driven by opioids including heroin and fentanyl. California ranks in the top five states when it comes to the raw number of drug-overdose deaths. Enough prescription opioids are prescribed every year to kill every Californian more than twice. Further, in some counties, more opioid related prescriptions are written than there are people in the county. The sheer number of opioid prescriptions written lends itself to the conclusion that many of these prescriptions may be obtained through fraudulent means such as doctor shopping, stolen or forged prescription pads, and the altering of legitimate prescriptions to increase quantity and or frequency of refills.”
The Author states that e-prescribing for controlled substances would “significantly reduce, if not eliminate paper-based fraud and forgery while creating electronic records of controlled substance transactions, thereby strengthening surveillance and drug monitoring programs in California. Electronic controlled substance prescriptions cannot be altered or copied and are electronically trackable.”
Nine states have now passed e-prescribing laws for controlled substances and
17 states, including California, have laws pending. States with existing laws include large states like New York and smaller, rural states such as Maine and Rhode Island.
In addition to the issue of fraudulent prescriptions, a 2017 report from the US Department of Health and Human Services’ Agency for Healthcare Research and Quality stated that prescription medication use is “widespread, complex, and increasingly risky”. Clinicians have access to thousands upon thousands of prescription medications and nearly one-third of adults in the United States take 5 or more medications. According to a July 2017 study published in the journal Clinical Toxicology, more than 1.3 million people are injured by medication errors annually in the United States. According to the same report, most of the mistakes were preventable.
A study conducted at a Johns Hopkins Medication outpatient pharmacy reported that 89% of handwritten prescriptions failed to meet best practice guidelines or were missing information that would otherwise be prompted by an e-prescribing system. By comparison, not a single prescription issued electronically in that study contained these types of errors. E-prescribing would significantly reduce medication errors.
- Background.
Prescriptions and E-Prescribing. Written prescriptions have been regulated in the State of California since 1929, when a statute was first enacted to require that certain drugs be dispensed only with a written prescription from a licensed physician, dentist, or veterinarian. These prescriptions were required to include the name and address of the individual receiving the drug, and for three years all prescription records were required to remain “open to inspection by the prescriber and properly authorized officers of the law, including all inspectors of the division of narcotic enforcement and of the state board of pharmacy.” This requirement was later expanded to include all prescription drugs.
Electronic prescribing is lauded as a key component in the future of health care. Efforts have been underway at the state and federal level to modernize systems while enhancing the quality of care, raising levels of patient safety and realizing cost savings. In 2004, the President announced a plan to ensure that electronic health records were available to most Americans by 2014, and key components of the federal American Reinvestment and Recovery Act were designed to promote the expansion of health information technology initiatives. Streamlining the practice of medicine to be more efficient through tools such as electronic prescribing and electronic health care records has the potential to, among other benefits, minimize dangerous prescription errors.
A November 2008 issue brief by the California HealthCare Foundation (CHCF) entitled, "The Outlook for Electronic Prescribing in California" reported that in 2007, California's retail pharmacies (excluding Kaiser and the Veterans Administration) filled more than 268 million prescriptions, but, of these transactions, only about 2.4 million were sent electronically between physician practices and pharmacies. While this amount is a significant improvement from the 311,097 recorded in 2005, it represents only 1.2 percent of the total prescriptions written in California each year. The CHCF report stated that the adoption of e-prescribing in California has been slow due to a number of possible reasons, including the cost involved in implementing the technology at provider practices, clinics and pharmacies, legal restrictions that prevent electronic prescribing of controlled substance prescriptions, and fees associated with using electronic prescribing networks.
Six other states have successfully mandated e-prescribing: Connecticut, Maine, North Carolina, New York, Rhode Island, and Virginia. Efforts to pass a federal mandate through the United States Congress continue with the introduction of the Every Prescription Conveyed Securely Act by Reps. Clark and Mullin, which would mandate e-prescribing for all Medicare Part D transactions by 2020. This federal legislation is supported by major retail pharmacies like CVS Health and Walgreens.
In a 2016 report, Surescripts, a health information network, stated that an estimated 73 percent of all prescriptions in the United States are now completed electronically. However, this number is only 14 percent of prescriptions for controlled substances. Implementing mandatory electronic transmission of prescriptions in California would represent significant progress for those in support of promoting the e-prescribing nationally.
Controlled Substances Prescribing, PDMPs and CURES. Through the Controlled Substances Act of 1970, the federal government regulates the manufacture, distribution and dispensing of controlled substances. The act ranks into five schedules those drugs known to have potential for physical or psychological harm, based on three considerations: (a) their potential for abuse; (b) their accepted medical use; and, (c) their accepted safety under medical supervision.
Schedule I controlled substances have a high potential for abuse and no generally accepted medical use such as heroin, ecstasy, and LSD.
Schedule II controlled substances have a currently accepted medical use in treatment, or a currently accepted medical use with severe restrictions, and have a high potential for abuse and psychological or physical dependence. Schedule II drugs can be narcotics or non-narcotic. Examples of Schedule II controlled substances include combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), morphine, methadone, Ritalin, Demerol, Percocet, Percodan, fentanyl and Oxycontin.
Schedule III and IV controlled substances have a currently accepted medical use in treatment, less potential for abuse but are known to be mixed in specific ways to achieve a narcotic-like end product. Examples include Tylenol with codeine, testosterone, Xanax, Ambien and other anti-anxiety drugs.
Schedule V drugs have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.
In 2010, the DEA revised regulations to provide health care practitioners with the option of issuing e-prescriptions for controlled substances. The regulations also permit pharmacies to receive, dispense, and archive e-prescriptions. Under the DEA rules, prescribing practitioners are still able to write, and manually sign, prescriptions for schedule II, III, IV, and V controlled substances and pharmacies are still able to dispense controlled substances based on those written prescriptions. Oral prescriptions remain valid for schedule III, IV, and V controlled substances. E-prescriptions for controlled substances are only permissible if the electronic prescription and the pharmacy application meet DEA's requirements, including:
- Identity proofing of individual prescribing practitioners. Individual practitioners apply to certain federally approved credential service providers (CSPs) or certification authorities (CAs) to obtain their two-factor authentication credential or digital certificate. The CSP or CA will be required to conduct identity proofing that meets National Institute of Standards and Technology Special Publication 800-63-1 Assurance Level 3. Both in person and remote identity proofing will be acceptable. DEA expects application providers will work with CSPs or CAs to direct practitioners to one or more sources of two-factor authentication credentials that will be interoperable with their applications. Prescribing practitioners may wish to contact their application provider to determine which CSP or CA the provider recommends the practitioner use. The specifics of each application will determine what kind of two-factor credential will be needed.
- Two-factor authentication credentials. According to DEA, two-factor authentication protects the practitioner from misuse of his/her credential by insiders as well as protecting him/her from external threats because the practitioner can retain control of a biometric or hard token. Under the rule, DEA allows the use of two of the following – something you know (a knowledge factor), something you have (a hard token stored separately from the computer being accessed), and something you are (biometric information). A hard token is a cryptographic key stored on a hardware device (e.g., a PDA, cell phone, smart card, USB drive, one-time password device) rather than on a general purpose computer. A hard token is a tangible, physical object possessed by an individual practitioner. The practitioner must retain sole possession of the hard token, where applicable, and must not share the password or other knowledge factor with any other person. The practitioner must not allow any other person to use the token or enter the knowledge factor or other identification means to sign prescriptions for controlled substances. Failure by the practitioner to secure the hard token or knowledge factor may provide a basis for revocation or suspension of the practitioner's DEA registration. Any biometric that meets the criteria DEA has specified may be used as the biometric factor in a two-factor authentication credential used to indicate that prescriptions are ready to be signed and sign controlled substance prescriptions. DEA notes that the use of biometrics as one factor in the two-factor authentication protocol is strictly voluntary, as is all electronic prescribing of controlled substances.
- Access controls. Any application that meets DEA's requirements will require access controls to ensure that only individuals legally authorized to sign controlled substance prescriptions are allowed to do so. Setting access controls requires two people. One person must determine which individuals are authorized to sign controlled substance prescriptions and enter those names or assign those names to a role that is allowed to sign controlled substance prescriptions. A DEA registrant must then use his/her two-factor credential to execute the access control list. The access control list will need to be updated when registrants join or leave a practice.
The DEA regulations specify that e-prescriptions for controlled substances may be subject to state laws and regulations but note that if state requirements are more stringent than DEA's regulations, the state requirements would supersede any less stringent DEA provision.
With rising levels of prescription drug abuse, prescription drug monitoring programs (PDMPs) assist law enforcement and regulatory bodies with their efforts to reduce drug abuse and diversion. In California, CURES is an electronic tracking program that reports all pharmacy (and specified types of prescriber) dispensing of certain schedules of controlled drugs by drug name, quantity, prescriber, patient, and pharmacy. Data from CURES is managed by DOJ. Information tracked in CURES contains the patient name, prescriber name, pharmacy name, drug name, amount and dosage, and is available to law enforcement agencies, regulatory bodies, prescribers, dispensers, and qualified researchers. CURES provides information to identify if a person is “doctor shopping” (when a patient, often a prescription-drug addict, visits multiple doctors to obtain multiple prescriptions for drugs, or uses multiple pharmacies to obtain prescription drugs). The system can also report on the top drugs prescribed for a specific time period, drugs prescribed in a particular county, doctor prescribing data, pharmacy dispensing data, and is a critical tool for assessing whether multiple prescriptions for the same patient may exist.
Every dispenser of controlled substances and every health practitioner authorized by the DEA to prescribe controlled substances is required to obtain a login for access to CURES. For each dispensed Schedule II, III, or IV drug, pharmacists and other dispensers are required to report basic information about the patient and their prescription within 7 days. This information is then made available to other system users in a variety of possible contexts. For example, physicians may query a patient’s prescription history prior to writing a new prescription; pharmacists can check the system before agreeing to fill a prescription for a controlled substance; regulators may review a licensee’s prescribing practices as part of a disciplinary investigation; and law enforcement can incorporate a search of the system into a potential criminal case of drug diversion.
Over 50 million prescription records have been uploaded into the system by dispensers since the beginning of the CURES program. As of January 1, 2018, 170,422 users had been approved for access to the system. Last year, close to 10 million activity reports had been processed by practitioners, pharmacists, law enforcement, and regulatory users. The vast majority of these searches (over 99 percent) were queries made by prescribers and dispensers seeking to review a patient’s prescription history as a component of exercising informed clinical judgment before providing access to opioids or other controlled substances.
Health practitioners will soon be required to consult the CURES database prior to writing a prescription for a Schedule II, III, or IV drug for the first time, and then at least once every four months as long as the prescription continues to be renewed (DOJ certified the system for statewide use on March 31, 2017; consultation requirements for prescribers outlined in SB 482 [Lara, Chapter 708, Statutes of 2016] take effect six months after DOJ certifies the system). Other recently enacted statutes require the DOJ to facilitate interoperability between health information technology systems and the CURES database, subject to a memorandum of understanding setting minimum security and privacy requirements.
- Prior Related Legislation. SB 1258 (DeSaulnier) of 2014 would have made several changes to the ways that controlled substances are prescribed and tracked in the CURES and would have required medical providers to use electronic prescribing systems, would have required additional reporting of controlled substance prescribing, and would have placed additional restrictions on the prescribing of controlled substances. (Status: The bill was held in the Senate Committee on Appropriations.)
AB 2516 (Mendoza) of 2008 required a doctor to ensure that any prescription he or she makes be electronically transmitted to a patient’s pharmacy of choice. (Status: The measure was never heard in a policy committee of the Legislature.)
ABX1 (Nunez) of 2007 would have required, by January 1, 2012 all prescribers, prescribers’ agents, and pharmacies, have ability to transmit and receive e-prescriptions, and would have given licensing boards the authority to enforce this requirement. (Status: The measure failed passage in the Senate Committee on Health.)
- Arguments in Support. The California Association of Health Underwriters believes that this bill will decrease the associated high costs of prescription drugs on healthcare premiums and will improve safety and quality of life.
The California Pharmacists Association writes in support, “CPhA has a long-standing policy to “support the use of electronic methods for the transmittal of prescriptions and other patient care information provided that adequate safeguards are in place to prevent and detect inappropriate or unauthorized transmittals.” “Technology is a key component pf the current healthcare system, improving patient outcomes. We see e-prescribing as part of this evolution.”
OCHIN writes in support, “Electronic controlled substance prescriptions cannot be altered, cannot be copied and are electronically trackable.”
- Support if Amended. The California Medical Board writes in support of this bill if it is amended and requests amendments to provide an exception or provide assistance to prescribers in rural areas and the California Dental Association writes in support of this bill if amended to delay the implementation of this bill until January 1, 2021.
- Arguments in Opposition. The California Society of Plastic Surgeons writes in opposition, “Like many physicians’ offices, the vast majority of plastic surgery practices are organized as small or solo physician practices. The cost for electronic medical records (EMR) systems which would also allow for electronic prescribing is significant to these small practices.”
The California Medical Association (CMA) and the California Academy of Family Physicians (CAFP) and are opposed unless amended and request amendments to extend the implementation deadline and exempt certain practices. According to CMA, “only 21 percent of physicians have adopted electronic prescribing for controlled substances (EPCS) through the DEA because the DEA system is antiquated, costly, and burdensome. Physicians, particularly those in small and rural practices, have experienced major difficulties with the DEA requirements and therefore, physicians’ ability to e-prescribe controlled substances has been dramatically lower than general e-prescribing. An EPCS mandate would unnecessarily require physicians to absorb significant additional costs. It is an unfunded mandate on physicians. It would create an enormous regulatory burden on resource-strapped small and rural practices, which would force them to stop prescribing altogether and patients with legitimate needs would not be served. Patients in need of appropriate pain care would suffer. Instead, the Legislature should focus on urging the DEA update and reduce the burdensome process by a date certain. The DEA’s technology is so outdated it cannot even recognize Apple products or fingerprinting scanners commonly used in banking and electronic medical records. Physicians are forced to purchase additional systems from the few monopolistic vendors approved by the DEA that are not integrated with physicians’ other systems – such as their Electronic Health Record. The problems with the DEA system have been well documented.
CAFP is also asking for a “retirement exemption” to exempt physicians within a short time of retirement; an exemption of smaller physician practices, including those in rural communities and solo practices, who do not have the prescription volume to justify the cost of a new e-prescribing system; a cost exemption for providers who may suffer a financial hardship by implementing the new e-prescribing system and an amendment to remove the language stating that it is “unprofessional conduct” for noncompliance of any provision of this bill.
The California Chapter of the American College of Emergency Physicians is opposed unless the bill is amended to exempt emergency departments.
According to the Osteopathic Physicians and Surgeons of California, more time is needed to allow physicians and other prescribers to ensure they are compliant with the bill and argues that small practices with few physicians and rural practices without access to e-prescribing technology or adequate Internet connectivity may be perpetually unable to comply, or exposed to undue hardship by attempting to comply.
- Proposed Author’s Amendments. In response to concerns raised by opponents above, the Author has proposed the following changes to the bill (as outlined in the mockup below):
- Delay implementation of the bill until 2022.
- Clarify circumstances in emergency care situations where e-prescriptions are not required (while specifying that the prescription must be electronically issued), including a prescription issued in a hospital emergency department or urgent care clinic when the patient resides outside California; when the patient resides outside the geographic service area of the hospital; when the patient is homeless or indigent and does not have a regular or preferred pharmacy; and when the prescription is issued at a time when a patient’s regular or preferred pharmacy is likely to be closed.
- Update language in the bill currently establishing unprofessional conduct for a violation to instead specify that a health care practitioner who fails to meet the electronic capability standards and who fails to e-prescribe shall be referred to the appropriate state professional licensing board solely for administrative sanctions, as deemed appropriate by that board. The changes specify that this section does not create a private right or action against a health care practitioner and does not limit a health care practitioner’s liability for the negligent failure to diagnose or treat a patient.
SUPPORT AND OPPOSITION:
Support:
America’s Physician Groups
California Association of Health Underwriters
California Dental Association
California Pharmacists Association
Medical Board of California
OCHIN
Opposition:
California Academy of Family Physicians
California Chapter of the American College of Emergency Physicians
California Medical Association
California Society of Plastic Surgeons
Osteopathic Physicians and Surgeons of California
-- END –
Mockup of AB 2789 as proposed to be amended
The people of the State of California do enact as follows:
SECTION 1. Section 688 is added to the Business and Professions Code, to read:
688. (a) On and after January 1, 20220, a health care practitioner authorized to issue a prescription pursuant to Section 4040 shall have the capability to issue an electronic data transmission prescription, as defined under Section 4040, on behalf of a patient and to transmit that electronic data transmission prescription to a pharmacy selected by the patient.
(b) On and after January 1, 20220, a pharmacy, pharmacist, or other practitioner authorized under California law to dispense or furnish a prescription pursuant to Section 4040 shall have the capability to receive an electronic data transmission prescription on behalf of a patient.
(c) For a prescription for a controlled substance, as defined by Section 4021, generation and transmission of the electronic data transmission prescription shall comply with Parts 1300, 1304, 1306, and 1311 of Title 21 of the Code of Federal Regulations, as amended from time to time.
(d) On and after January 1, 20221, a prescription prescribed by a health care practitioner shall be issued as an electronic data transmission prescription. This subdivision shall not apply to prescriptions issued pursuant to subdivision (e).
(e) Subdivision (d) shall not apply to any of the following:
(1) The prescription is issued pursuant to Section 11159.2 of the Health and Safety Code.
(2) An electronic data transmission prescription is not available due to a temporary technological or electrical failure. For purposes of this paragraph, “temporary technological or electrical failure” means failure of a computer system, application, or device, or the loss of electrical power to that system, application, or device, or any other service interruption affecting the certified electronic data transmission prescription application used to transmit the prescription.
(3) The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
(4) The prescription is issued in a hospital emergency department or urgent care clinic when one or more of the following conditions are present:
A) The patient resides outside California;
B) The patient resides outside the geographic service area of the hospital;
C) The patient is homeless or indigent and does not have a regular or preferred pharmacy; and,
D) The prescription is issued at a time when a patient’s regular or preferred pharmacy is likely to be closed.
Under the above conditions a prescription must be electronically issued but does not require electronic transmission and may be provided directly to the patient.
(4) The prescription is issued by a veterinarian.
(5) The prescription is for eyeglasses or contact lenses.
(6) The prescribing health care practitioner and the dispenser are the same entity.
(7) The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances prescribed by an electronic data transmission prescription in a timely manner, and the delay would adversely impact the patient’s medical condition.
(8) The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs’ SCRIPT standard, as amended from time to time.
(f) A health care practitioner who issues a prescription for a controlled substance but does not transmit the prescription as an electronic data transmission prescription shall document the reason in the patient’s medical record as soon as practicable and within 72 hours of the end of the technological or electrical failure that prevented the electronic data transmission of the prescription.
(g) A pharmacy that receives an electronic data transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient may, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic data transmission prescription to an alternative pharmacy designated by the requester.
(h) If a pharmacy, or its staff, is aware than an attempted transmission of an electronic data transmission prescription failed, is incomplete, or is otherwise not appropriately received, the pharmacy shall immediately notify the prescribing health care practitioner.
(i) A pharmacist who receives a written, oral, or faxed prescription shall not be required to verify that the prescription properly falls under one of the exceptions in subdivision (e). Pharmacists may continue to dispense medications from legally valid written, oral, or fax prescriptions pursuant to this division.
(j) Notwithstanding any other law, a violation of this section constitutes unprofessional conduct and grounds for disciplinary action by the health care practitioner’s licensing board. A health care practitioner who fails to meet the electronic capability standards of Section 688 (a) or (b) and who fails to electronically transmit prescriptions as required by 688(d) shall be referred to the appropriate state professional licensing board solely for administrative sanctions, as deemed appropriate by that board. This section does not create a private right or action against a health care practitioner. This section does not limit a health care practitioner’s liability for the negligent failure to diagnose or treat a paient.
ASSEMBLY THIRD READING
ATR Bill Id:AB 2789
Author:(Wood)
As Amended Ver:April 3, 2018
Majority vote
Committee | Votes | Ayes | Noes |
Business & Professions | 10-1 | Low, Bloom, Chiu, Eggman, Gipson, Grayson, Holden, Irwin, Mullin, Ting | Brough |
Appropriations | 13-2 | Gonzalez Fletcher, Bloom, Bonta, Calderon, Carrillo, Chau, Eggman, Friedman, Eduardo Garcia, Nazarian, Obernolte, Quirk, Reyes | Bigelow, Brough |
SUMMARY: Requires that all health care practitioners authorized to issue prescriptions to be capable of electronically prescribing by January 1, 2020, and requires that all prescriptions for controlled substances be transmitted electronically beginning January 1, 2021, with exceptions. Specifically, this bill:
- Requires, on and after January 1, 2020, every health care practitioner authorized to issue a prescription to have the capability to issue an electronic data transmission prescription on behalf of a patient and to transmit that electronic data transmission prescription to a pharmacy selected by the patient.
- Requires, on and after January 1, 2020, every pharmacy, pharmacist, or other dispenser to have the capability to receive an electronic data transmission prescription on behalf of a patient.
- Requires, on and after January 1, 2021, that every prescription for a controlled substance be issued as an electronic data transmission prescription, except for in the following cases:
- The prescription is for a controlled substance for use by a patient who has a terminal illness.
- An electronic data transmission prescription is not available due to a temporary technological or electrical failure.
- The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
- The prescription is issued by a veterinarian.
- The prescription is for eyeglasses or contact lenses.
- The prescribing health care practitioner and the dispenser are the same entity.
- The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances prescribed by an electronic data transmission prescription in a timely manner, and the delay would adversely impact the patient's medical condition.
- The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs' SCRIPT standard, as amended from time to time.
- Requires a practitioner who issues a prescription for a controlled substance in a way other than by electronic data transmission to document the reason in the patient's medical record.
- Allows a pharmacy that receives an electronic data transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient to, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic data transmission prescription to an alternative pharmacy designated by the requester.
- Requires a pharmacy to immediately notify a prescriber in the event that the pharmacy, or its staff, is aware than an attempted transmission of an electronic data transmission prescription failed, is incomplete, or is otherwise not appropriately received.
- States that a pharmacist is not required to verify that a prescription received in a way other than by electronic data transmission was appropriately subject to one of the valid exceptions.
- Makes a violation of this section constitute unprofessional conduct and grounds for disciplinary action by the health care practitioner's licensing board.
FISCAL EFFECT: According to the Assembly Committee on Appropriations, minor and absorbable costs to the Board of Pharmacy and the California Medical Board within the Department of Consumer Affairs to create new codes in relevant information technology systems to track violations (special funds).
COMMENTS:
Purpose. This bill is sponsored by the author. According to the author:
Health care is becoming more and more complex. Electronic Health Records are becoming the norm. The ever increasing reporting requirements to CURES [Controlled Substance Utilization Review and Evaluation System] for controlled substances, the proliferation of more and new drugs, the increased numbers of prescriptions written annually, the increase in total numbers of prescriptions individuals are receiving, the risk of errors, the ongoing issue of fraudulent prescriptions and the diversion of prescription medicines into street drugs with oftentimes deadly results all point to the need for electronic prescribing of drugs. A study conducted at a Johns Hopkins Medication outpatient pharmacy reported that 89% of handwritten prescriptions failed to meet best practice guidelines or were missing information that would otherwise be prompted by an e-prescribing system. By comparison, not a single prescription issued electronically in that study contained these types of errors. E-prescribing would address several of the issues identified with the existing prescription requirements.
Adoption of technology to improve patient outcomes has always been a hallmark of the medical profession and the adoption of e-prescribing is no exception.
Background.
Overview of the Opioid Crisis. In October of 2017, the White House declared the opioid crisis a public health emergency, formally recognizing what had long been understood to be a growing epidemic responsible for devastation in communities across the country. According to the Centers for Disease Control and Prevention, as many as 50,000 Americans died of an opioid overdose in 2016, representing a 28% increase over the previous year. Additionally, the number of Americans who died of an overdose of fentanyl and other opioids more than doubled during that time with nearly 20,000 deaths. These death rates compare to, and potentially exceed, those at the height of the AIDS epidemic.
Opioids are a class of drugs prescribed and administered by health professionals to manage pain. Modern use of the term "opioid" typically describes both naturally occurring opiates derived from the opium poppy as well as their manufactured synthetics. Common examples of prescription opioids include oxycodone (OxyContin, Percocet); hydrocodone (Vicodin, Norco, Lorcet); codeine; morphine; and fentanyl. Heroin is also an opioid.
In addition to providing pain relief, opioids can be used as a cough suppressant, an antidiarrheal, a method of sedation, and a treatment for shortness of breath. The majority of pharmaceutical opioids are Schedule II drugs under the federal Controlled Substances Act, considered by the federal Drug Enforcement Agency (DEA) to have a high potential for abuse that may lead to severe psychological or physical dependence. However, combination drugs containing lower doses of opioids combined with other active ingredients are typically less restricted; for example, cough syrups containing low doses of codeine are frequently classified Schedule V medications.
The abuse of prescription drugs was historically viewed as a criminal concern analogous to street narcotics cases regularly investigated by law enforcement. In recent years, however, an expert consensus has evolved around the opinion that the opioid crisis must be addressed through the lens of public health policy. This belief is supported by research demonstrating how health professionals may have inadvertently contributed to the origins of the crisis. It is widely accepted that health professionals will play a necessarily critical role in any meaningful solutions.
In the opioid crisis' broader national context, there has been a persistent perception that California represents a relatively minor segment of an epidemic more typically identified with states like New Hampshire and West Virginia. However, there is substantial evidence that communities in California have been much harder hit than may be generally believed. For example, in 2015, several rural counties in California saw as many or more drug overdose deaths per 100,000 residents than some Midwestern states. It has been reported than some small counties had more opioid prescriptions than residents. In total, the California Department of Public Health estimates that nearly 2,000 Californians died of an opioid overdose in 2016.
In February of 2018, a bipartisan coalition of California State Assemblymembers announced a package of legislation aimed at combating the opioid crisis. The bills have been presented as representing a diversity of approaches to curbing overprescription, encouraging treatment, and preventing diversion. The potential of each proposed measure to effectively address the epidemic of prescription drug abuse must be evaluated in proportion to any added burden to those health professionals who remain tasked with ensuring that legitimate treatment continues to be provided to patients with pain management needs.
Electronic Prescribing. Many public health advocates have long championed electronic prescribing (or "e-prescribing") as one of the most effective ways to combat prescription fraud and drug diversion. Studies dating as far back as 2000 recommended phasing out paper prescription pads in favor of mandatory e-prescribing. A cultural inertia in regards to technology that persists in the medical profession, combined with concerns about whether a sufficient number of practitioners’ offices are technologically sophisticated enough to adapt to a mandate, has traditionally represented a strong barrier to any institutionalized change. This has remained relatively true even as electronic health records, specialized smartphone apps, and broadband internet access continue to become commonplace in the medical profession.
In 2008, the California Health Care Foundation issued a report entitled The Outlook for Electronic Prescribing in California, which stated that only 1.2% of prescriptions filled by California’s community pharmacies were sent electronically. The report blamed cost, legal restrictions, and technology fees for the slow adoption rate. That same year, the United States Congress passed the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA), which incentivized e-prescribing among practitioners and providers and penalized those who did not adopt the technology within a few years.
Six other states have successfully mandated e-prescribing: Connecticut, Maine, North Carolina, New York, Rhode Island, and Virginia. Efforts to pass a federal mandate through the United States Congress continue with the introduction of the Every Prescription Conveyed Securely Act by House Representatives Clark and Mullin, which would mandate e-prescribing for all Medicare Part D transactions by 2020. This federal legislation is supported by major retail pharmacies like CVS Health and Walgreens.
In a 2016 report, Surescripts, a health information network, stated that an estimated 73% of all prescriptions in the United States are now completed electronically. However, this number is only 14% of prescriptions for controlled substances. Implementing mandatory electronic transmission of prescriptions in California would represent significant progress for those in support of promoting the e-prescribing nationally.
ARGUMENTS IN SUPPORT:
Imprivata, a health technology company, is in support of this bill. Imprivata writes that "California, and our nation, is facing an opioid crisis of epic proportions, and while the solution to this crisis is in our grasp, it is not being fully employed." Imprivata goes on to state that "forged, altered, and stolen opiate prescriptions are the most common way that prescription opiates fall into the wrong hands. From doctor shopping to the theft of prescription pads, the diversion of pharmaceuticals represent a serious problem in the opioid crisis, and is a direct symptom of a prescription system that is not functioning as it should." Imprivata believes that mandating e-prescribing is the appropriate way to solve this problem.
The California State Board of Pharmacy also supports this bill. The board explains that "in 2016, 1.6 billion prescriptions were issued electronically in the US [United States], so e-prescribing is no longer a future technology." The board states that legislation mandating e-prescribing would "benefit California as we continue to grapple in multiple ways with methods to reduce the impact of the opioid crisis."
America's Physician Groups (APG), representing approximately 300 medical groups and independent practice association, supports AB 2789. APG writes that "electronic prescribing provides numerous benefits to patients and the health care system including:
- Reducing paper-based fraud of prescriptions;
- Facilitating and expediting communications between prescribers and pharmacies;
- Reducing medical errors and assisting providers with patient medication histories; and
- Facilitating the collection and utilization of data."
ARGUMENTS IN OPPOSITION:
The California Medical Association (CMA) has taken an "oppose unless amended" position on the bill. CMA states that it cannot support the bill "unless amendments are taken which will make the transition to electronic prescribing a process with a longer implementation time and appropriate exemptions." Specifically, CMA believes that additional time should be allowed for prescribers to comply, and that a "retirement exemption" should be added to exempt physicians within a short time of retirement. CMA also requests an exemption for small practices consisting of five or fewer prescribing physicians.
Analysis Prepared by: Robert Sumner / B. & P. / (916) 319-3301 FN: 0002739
Date of Hearing: April 25, 2018
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Lorena Gonzalez Fletcher, Chair
ABPCA Bill Id:AB 2789
Author:(Wood) – As Amended Ver:April 3, 2018
Policy Committee: | Business and Professions | Vote: | 10 - 1 |
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill mandates e-prescribing for prescribers and drug dispensers. Specifically, this bill:
- Requires, on or after January 1, 2020, prescribers to have the capability to issue prescriptions electronically and dispensers (often pharmacies) to have the ability to receive such prescriptions.
- Requires a prescription to be issued as an electronic data transmission as of January 1, 2021.
- Provides numerous exceptions to (2), including for veterinary prescriptions, eyeglass or contact lens prescriptions, and situations in which the prescriber and dispenser are the same entity, among others.
FISCAL EFFECT:
- Minor and absorbable costs to the Board of Pharmacy and the California Medical Board within the Department of Consumer Affairs to create new codes in relevant information technology systems to track violations (special funds).
- Staff interprets state health care delivery systems—for instance, correctional health care— as exempt from this mandate; therefore, no fiscal effect on such state systems is expected.
COMMENTS:
- Purpose. The author cites numerous reasons e-prescribing should be required in the state, including an increased number and complexity of prescriptions, the risk of errors, fraudulent prescriptions, and the diversion of prescribed controlled substances to street use.
- Background. Universal e-prescribing has been discussed and debated in health policy circles over the last two decades. The adoption of electronic health records has accelerated significantly over the last decade, and now most prescriptions are sent electronically. Additionally, most prescribers and dispensers are already compliant with this bill. Studies have noted e-prescribing has numerous advantages over handwritten prescriptions.
- Support and Opposition. A diverse set of supporters include California Association of Health Underwriters, the state Board of Pharmacy, and the Healthcare Distribution Alliance. The California Medical Association is opposed unless amended to provide a longer implementation time, a "retirement exemption," and an exemption for small practices.
Analysis Prepared by: Lisa Murawski / APPR. / (916) 319-2081
Date of Hearing: April 10, 2018
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Evan Low, Chair
ABPCA Bill Id:AB 2789
Author:(Wood) – As Amended Ver:April 3, 2018
SUBJECT: Health care practitioners: prescriptions: electronic data transmission.
SUMMARY: Requires that all health care practitioners authorized to issue prescriptions to be capable of electronically prescribing by January 1, 2020 and requires that all prescriptions for controlled substances be transmitted electronically beginning January 1, 2021, with exceptions.
EXISTING LAW:
- Allows only a physician, dentist, podiatrist, veterinarian, naturopathic doctor, registered nurse, certified nurse-midwife, optometrist, or out-of-state prescriber to write or issue a prescription. (Health and Safety Code (HSC) § 11150)
- States that a prescription for a controlled substance shall only be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his or her professional practice, and that the responsibility for the proper prescribing and dispensing of controlled substances is upon the prescribing practitioner, but a corresponding responsibility rests with the pharmacist who fills the prescription. (HSC § 11153)
- Prohibits medical professionals from prescribing, administering, or dispensing a controlled substance to an addict, as defined. (HSC § 11156)
- Requires that all prescription forms for controlled substance prescriptions be obtained from security printers approved by the Department of Justice (DOJ) and sets a number of parameters for the DOJ’s approval process. (HSC § 11161.5)
- Provides that when a prescriber’s authority to prescribe controlled substances is restricted, the law enforcement agency or licensing board that sought the restrictions shall provide the prescriber’s name, category of licensure, license number, and the nature of the restrictions imposed on the prescriber to security printers, the DOJ, and the Board of Pharmacy. (HSC § 11161.7)
- Lists a number of required features that must be included for all prescription forms for controlled substances, including fraud-prevention identifiers, printing information, and information relating to the prescribing practitioner. (HSC § 11162.1)
- Criminalizes the counterfeiting of prescription pads and the possession of counterfeit prescription pads. (HSC §§ 11162.5-11162.6)
- Enables security printers and prescribers to report stolen or lost prescription pads to the DOJ through the Controlled Substance Utilization Review and Evaluation System (CURES). (HSC § 11165.3)
- Requires all prescriptions and dispensations of controlled substances to meet a series of requirements including use of a controlled substance prescription form, presence of a signature and date in ink, and the address of the patient. (HSC § 11164)
- Prohibits any person from obtaining or attempting to obtain a prescription for controlled substances, by fraud, deceit, misrepresentation, subterfuge, or the concealment of a material fact. (HSC § 11173)
- Defines “electronic data transmission prescription” as any prescription order, other than a facsimile, that is electronically transmitted from a licensed prescriber to a pharmacy. (Business and Professions Code (BPC) § 4040)
THIS BILL:
- Requires, on and after January 1, 2020, every health care practitioner authorized to issue a prescription to have the capability to issue an electronic data transmission prescription on behalf of a patient and to transmit that electronic data transmission prescription to a pharmacy selected by the patient.
- Requires, on and after January 1, 2020, every pharmacy, pharmacist, or other dispenser to have the capability to receive an electronic data transmission prescription on behalf of a patient.
- Requires, on and after January 1, 2021, that every prescription for a controlled substance be issued as an electronic data transmission prescription, except for in the following cases:
- The prescription is for a controlled substance for use by a patient who has a terminal illness.
- An electronic data transmission prescription is not available due to a temporary technological or electrical failure.
- The prescribing health care practitioner is issuing a prescription to be dispensed by a pharmacy located outside California.
- The prescription is issued by a veterinarian.
- The prescription is for eyeglasses or contact lenses.
- The prescribing health care practitioner and the dispenser are the same entity.
- The prescription is issued by a prescribing health care practitioner under circumstances whereby the practitioner reasonably determines that it would be impractical for the patient to obtain controlled substances prescribed by an electronic data transmission prescription in a timely manner, and the delay would adversely impact the patient’s medical condition.
- The prescription that is issued includes elements not covered by the latest version of the National Council for Prescription Drug Programs’ SCRIPT standard, as amended from time to time.
- Requires a practitioner who issues a prescription for a controlled substance in a way other than by electronic data transmission to document the reason in the patient’s medical record.
- Allows a pharmacy that receives an electronic data transmission prescription from a prescribing health care practitioner who has issued the prescription but has not dispensed the medication to the patient to, at the request of the patient or a person authorized to make a request on behalf of the patient, immediately transfer or forward the electronic data transmission prescription to an alternative pharmacy designated by the requester.
- Requires a pharmacy to immediately notify a prescriber in the event that the pharmacy, or its staff, is aware than an attempted transmission of an electronic data transmission prescription failed, is incomplete, or is otherwise not appropriately received.
- States that a pharmacist is not required to verify that a prescription received in a way other than by electronic data transmission was appropriately subject to one of the valid exceptions.
- Makes a violation of this section constitute unprofessional conduct and grounds for disciplinary action by the health care practitioner’s licensing board.
FISCAL EFFECT: Unknown; this bill is keyed fiscal by the Legislative Counsel.
COMMENTS:
Purpose. This bill is sponsored by the author. According to the author:
Health care is becoming more and more complex. Electronic Health Records are becoming the norm. The ever increasing reporting requirements to CURES for controlled substances, the proliferation of more and new drugs, the increased numbers of prescriptions written annually, the increase in total numbers of prescriptions individuals are receiving, the risk of errors, the ongoing issue of fraudulent prescriptions and the diversion of prescription medicines into street drugs with oftentimes deadly results all point to the need for electronic prescribing of drugs.
A study conducted at a Johns Hopkins Medication outpatient pharmacy reported that 89% of handwritten prescriptions failed to meet best practice guidelines or were missing information that would otherwise be prompted by an e-prescribing system. By comparison, not a single prescription issued electronically in that study contained these types of errors. E-prescribing would address several of the issues identified with the existing prescription requirements.
Adoption of technology to improve patient outcomes has always been a hallmark of the medical profession and the adoption of e-prescribing is no exception.
Background.
Overview of the Opioid Crisis. In October of 2017, the White House declared the opioid crisis a public health emergency, formally recognizing what had long been understood to be a growing epidemic responsible for devastation in communities across the country. According to the Centers for Disease Control and Prevention, as many as 50,000 Americans died of an opioid overdose in 2016, representing a 28 percent increase over the previous year. Additionally, the number of Americans who died of an overdose of fentanyl and other opioids more than doubled during that time with nearly 20,000 deaths. These death rates compare to, and potentially exceed, those at the height of the AIDS epidemic.
Opioids are a class of drugs prescribed and administered by health professionals to manage pain. Modern use of the term “opioid” typically describes both naturally occurring opiates derived from the opium poppy as well as their manufactured synthetics. Common examples of prescription opioids include oxycodone (OxyContin, Percocet); hydrocodone (Vicodin, Norco, Lorcet); codeine; morphine; and fentanyl. Heroin is also an opioid.
In addition to providing pain relief, opioids can be used as a cough suppressant, an antidiarrheal, a method of sedation, and a treatment for shortness of breath. The majority of pharmaceutical opioids are Schedule II drugs under the federal Controlled Substances Act, considered by the federal Drug Enforcement Agency (DEA) to have a high potential for abuse that may lead to severe psychological or physical dependence. However, combination drugs containing lower doses of opioids combined with other active ingredients are typically less restricted; for example, cough syrups containing low doses of codeine are frequently classified Schedule V medications.
The abuse of prescription drugs was historically viewed as a criminal concern analogous to street narcotics cases regularly investigated by law enforcement. In recent years, however, an expert consensus has evolved around the opinion that the opioid crisis must be addressed through the lens of public health policy. This belief is supported by research demonstrating how health professionals may have inadvertently contributed to the origins of the crisis. It is widely accepted that health professionals will play a necessarily critical role in any meaningful solutions.
In the opioid crisis’s broader national context, there has been a persistent perception that California represents a relatively minor segment of an epidemic more typically identified with states like New Hampshire and West Virginia. However, there is substantial evidence that communities in California have been much harder hit than may be generally believed. For example, in 2015, several rural counties in California saw as many or more drug overdose deaths per 100,000 residents than some Midwestern states. It has been reported than some small counties had more opioid prescriptions than residents. In total, the California Department of Public Health estimates that nearly 2,000 Californians died of an opioid overdose in 2016.
In February of 2018, a bipartisan coalition of California State Assemblymembers announced a package of legislation aimed at combating the opioid crisis. The bills have been presented as representing a diversity of approaches to curbing overprescription, encouraging treatment, and preventing diversion. The potential of each proposed measure to effectively address the epidemic of prescription drug abuse must be evaluated in proportion to any added burden to those health professionals who remain tasked with ensuring that legitimate treatment continues to be provided to patients with pain management needs.
Electronic Prescribing. Many public health advocates have long championed electronic prescribing (or “e-prescribing”) as one of the most effective ways to combat prescription fraud and drug diversion. Studies dating as far back as 2000 recommended phasing out paper prescription pads in favor of mandatory e-prescribing. A cultural inertia in regards to technology that persists in the medical profession, combined with concerns about whether a sufficient number of practitioners’ offices are technologically sophisticated enough to adapt to a mandate, has traditionally represented a strong barrier to any institutionalized change. This has remained relatively true even as electronic health records, specialized smartphone apps, and broadband internet access continue to become commonplace in the medical profession.
In 2008, the California Health Care Foundation issued a report entitled The Outlook for Electronic Prescribing in California, which stated that only 1.2 percent of prescriptions filled by California’s community pharmacies were sent electronically. The report blamed cost, legal restrictions, and technology fees for the slow adoption rate. That same year, the United States Congress passed the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA), which incentivized e-prescribing among practitioners and providers and penalized those who did not adopt the technology within a few years.
Six other states have successfully mandated e-prescribing: Connecticut, Maine, North Carolina, New York, Rhode Island, and Virginia. Efforts to pass a federal mandate through the United States Congress continue with the introduction of the Every Prescription Conveyed Securely Act by Reps. Clark and Mullin, which would mandate e-prescribing for all Medicare Part D transactions by 2020. This federal legislation is supported by major retail pharmacies like CVS Health and Walgreens.
In a 2016 report, Surescripts, a health information network, stated that an estimated 73 percent of all prescriptions in the United States are now completed electronically. However, this number is only 14 percent of prescriptions for controlled substances. Implementing mandatory electronic transmission of prescriptions in California would represent significant progress for those in support of promoting the e-prescribing nationally.
Current Related Legislation. AB 1751 (Low) would provide a framework for the CURES PDMP to connect with other states that comply with California’s patient privacy and data security standards.
AB 1752 (Low) would add Schedule V drugs to the CURES database and change the requirement for pharmacists to report dispensed prescriptions from seven days to the following business day.
AB 1753 (Low) would limit the number of security printers authorized to manufacture prescription pads and linking uniquely serialized pads with CURES.
AB 2384 (Arambula) would remove barriers to medication-assisted treatment, such as prior authorization requirements and limits on coverage.
AB 2741 (Burke) would limit all opioid prescriptions for minors to a maximum of 5 days, with exceptions, and require a prescriber to discuss risks related to opioid medication with the minor and the minor’s parent or guardian and obtain written consent prior to writing the prescription.
AB 2859 (Caballero) would increase safe storage practices among parents to prevent access to prescription drugs in the home by children and adolescents.
AB 2086 (Gallagher) would allow prescribers of controlled substances to review a list of patients for whom they are listed as being the prescriber.
AB 2487 (McCarty) would add opioid addiction training as a continuing medical education requirement for certain physicians in order to increase the availability of buprenorphine treatment.
AB 2486 (McCarty) would establish the Opioid Prevention and Rehabilitation Program Fund to treat opioid addiction by providing existing programs the additional funding.
AB 2783 (O’Donnell) would reconcile discrepancies between California’s controlled substance schedules and the corresponding federal controlled substance schedules.
AB 1963 (Waldron) would incentivize medical providers to become certified prescribers of medication-assisted treatment by increasing the reimbursement rates for providers who prescribe these drug treatments.
AB 2789 (Wood) would require that prescriptions be submitted electronically, with limited exceptions.
AB 2760 (Wood) would require certain prescriptions for opioids to also include a co-prescription for naloxone.
Prior Related Legislation. SB 1258 (DeSaulnier) of 2014 would have, among other things, mandated that controlled substances be prescribed electronically. This bill died on the Senate Appropriations Committee suspense file.
AB 2516 (Mendoza) of 2008 would have required a prescriber to ensure that any prescription issued or made by him or her be type-written and electronically transmitted to the patient’s pharmacy of choice. This bill died in the Assembly Business and Professions Committee.
ARGUMENTS IN SUPPORT:
Imprivata, a health technology company, is in support of AB 2789. Imprivata writes that “California, and our nation, is facing an opioid crisis of epic proportions, and while the solution to this crisis is in our grasp, it is not being fully employed.” Imprivata goes on to state that “forged, altered, and stolen opiate prescriptions are the most common way that prescription opiates fall into the wrong hands. rom doctor shopping to the theft of prescription pads, the diversion of pharmaceuticals represent a serious problem in the opioid crisis, and is a direct symptom of a prescription system that is not functioning as it should.” Imprivata believes that mandating e-prescribing is the appropriate way to solve this problem.
The California State Board of Pharmacy also supports the bill. The board explains that “in 2016, 1.6 billion prescriptions were issued electronically in the US, so e-prescribing is no longer a future technology.” The board states that legislation mandating e-prescribing would “benefit California as we continue to grapple in multiple ways with methods to reduce the impact of the opioid crisis.”
America’s Physician Groups (APG), representing approximately 300 medical groups and independent practice association, supports AB 2789. APG writes that “electronic prescribing provides numerous benefits to patients and the health care system including:
- Reducing paper-based fraud of prescriptions;
- Facilitating and expediting communications between prescribers and pharmacies;
- Reducing medical errors and assisting providers with patient medication histories; and
- Facilitating the collection and utilization of data.”
ARGUMENTS IN OPPOSITION:
The California Medical Association (CMA) has taken an “oppose unless amended” position on the bill. CMA states that it cannot support the bill “unless amendments are taken which will make the transition to electronic prescribing a process with a longer implementation time and appropriate exemptions.” Specifically, CMA believes that additional time should be allowed for prescribers to comply, and that a “retirement exemption” should be added to exempt physicians within a short time of retirement. CMA also requests an exemption for small practices consisting of 5 or fewer prescribing physicians.
REGISTERED SUPPORT:
America’s Physician Groups
California Association of Health Underwriters
California State Board of Pharmacy
Healthcare Distribution Alliance
Imprivata
REGISTERED OPPOSITION:
California Medical Association
Analysis Prepared by: Robert Sumner / B. & P. / (916) 319-3301
Discussed in Hearing
Assembly Floor
Senate Floor
Senate Standing Committee on Business, Professions and Economic Development
Assembly Floor
Assembly Standing Committee on Appropriations
Assembly Standing Committee on Business and Professions
Bill Author
Bill Co-Author(s):